Language selection

Search

Patent 2082076 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2082076
(54) English Title: PYRIDINE-2,4 AND -2,5-DICARBOXAMIDES AND THEIR DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE
(54) French Title: PYRIDINE-2,4 ET -2,5-DICARBOXAMIDES ET LEURS DERIVES, PROCEDE POUR LEUR PREPARATION, ET LEUR UTILISATION
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07D 213/81 (2006.01)
  • A61K 31/44 (2006.01)
  • A61K 31/495 (2006.01)
  • A61K 31/675 (2006.01)
  • C07D 213/82 (2006.01)
  • C07D 401/00 (2006.01)
  • C07D 405/00 (2006.01)
  • C07D 409/00 (2006.01)
  • C07D 413/00 (2006.01)
  • C07D 417/00 (2006.01)
  • C07F 9/58 (2006.01)
(72) Inventors :
  • WEIDMANN, KLAUS (Germany)
  • BICKEL, MARTIN (Germany)
  • GUENZLER-PUKALL, VOLKMAR (Germany)
  • SCHUBERT, GERRIT (Germany)
(73) Owners :
  • WEIDMANN, KLAUS (Not Available)
  • BICKEL, MARTIN (Not Available)
  • GUENZLER-PUKALL, VOLKMAR (Not Available)
  • SCHUBERT, GERRIT (Not Available)
  • HOECHST AKTIENGESELLSCHAFT (Germany)
(71) Applicants :
(74) Agent: BERESKIN & PARR LLP/S.E.N.C.R.L.,S.R.L.
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1992-11-04
(41) Open to Public Inspection: 1993-05-06
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 41 36 380.9 Germany 1991-11-05

Abstracts

English Abstract



HOE 91/F 350

Abstract of the Disclosure:
Pyridine-2,4- and -2,5-dicarboxamides and their deriva-
tives, process for their preparation, and their use
There are described pyridine-2,4- and -2,5-dicarboxamides
and their use as pharmaceuticals, in particular as
fibrosuppressants adn immunosuppressants.


Claims

Note: Claims are shown in the official language in which they were submitted.



- 43 - HOE 91/F 350
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A compound of the formula I

Image (I)

in which
R1, R2, R3 and R4 are identical or different and are
A a branched or unbranched, aliphatic or cyclo-
aliphatic (C1-C12)-alkyl radical, (C1-C12)-alkenyl
radical or a (C1-C12)-alkynyl radical, each of which
is monosubstituted or polysubstituted, preferably
monosubstituted or disubstituted,
by a (C1-C8)-alkoxycarbonyloxy, (C1-C8)-alkoxy-
(C1-C8)-alkoxycarbonyloxy, (C6-C12)-aryloxycarbonyl-
oxy, (C7-C11)-aralkyloxycarbonyloxy, (C7-C11)-aralkyl-
carbonyloxy, cinnamoyl, cinnamoyloxy, (C6-C12)-
arylcarbonyloxy, C3-C6)-alkenylcarbonyloxy, (C3-C8)-
alkynylcarbonyloxy, (C3-C6)-cycloalkylcarbonyloxy,
(C1-C12)-alkoxy-(C1-C12)-alkoxy, (C1-C12)-alkoxy-amino,
(C1-C12)-alkoxy-N (C1-C6)-alkylamino, (C1-C12)-alkoxy-
N,N-(C1-C6)-dialkylamino, carbamoyloxy, N-(C1-C8)-
alkylcarbamoyloxy, N,N-di-(C1-C8)-alkylcarbamoyl,
N-(C3-C6)-cycloalkylcarbamoyl, N-(C6-C12)-arylamino,
N-(C7-C11)-aralkylamino, N-alkyl-aralkylamino,
N-alkyl-arylamino, (C3-C6)-cycloalkanoylamino,
(C1-C6)-alkanoylamino, (C6-C12)-aroylamino, (C7-C11)-
aralkanoylamino, (C1-C8)-alkanoyl-(C1-C8)-alkylamino,
(C3-C6)-cycloalkanoyl-(C1-C8)-alkylamino, (C6-C12)-
aroyl-(C1-C6)-alkylamino, (C7-C11)-aralkanoyl-(C1-C6)-



- 44 -
alkylamino, (C1-C8)-alkylmercapto, (C1-C8)-alkyl-
sulfinyl, (C1-C8)-alkylsulfonyl, (C1-C8)-alkyl-
carbonyl, (C3-C8)-cycloalkylcarbonyl, nitro, tri-
flurormethyl, phenylmercapto, phenylsulfonyl,
phenylsulfinyl, sulfamoyl, N-(C1-C6)-alkylsulfamoyl,
N,N-di-(C1-C6)-alkylaulfamoyl, (C1-C8)-alkyl-sulfon-
amido and arylsulfonamido, where the aryl and
aralkyl radicals in the above substituents can also
have a heterocyclic nature and/or, like alkyl, are
substituted by 1, 2, 3, 4 or 5 identical or dif-
ferent substituents selected from the series com-
prising halogen, cyano, nitro, trifluoromethyl,
(C1-C6)-alkyl, hydroxyl, (C1-C6)-hydroxyalkyl,
(C1-C6)-alkoxy, -O-[CH2-]xCfH(2f+1-g)Fg, -OCF2Cl,
-O-CF2-CHFCl, trifluoromethyl (C1-C6)-alkylmercapto,
(C1-C6)-alkylsulfinyl, (C1-C6)-alkylsulfonyl, (C1-C8)-
alkylcarbonyl, (C1-C6)-alkoxycarbonyl, carbamoyl,
N-(C1-C4)-alkylcarbamoyl, N,N-di-(C1-C4)-alkyl-
carbamoyl, (C1-C6)-alkylcarbonyloxy, (C3-C8)-cyclo-
alkyl, phenyl, benzyl, phenoxy, benzyloxy, NR'-R",
phenylmercapto, phenylsulfonyl, phenylsulfinyl,
sulfamoyl, N-(C1-C4)-alkylsulfamoyl or N,N-di-(C1-C4)-
alkylsulfamoyl, in particular by up to 3 of the
abovementioned identical or different substituents,
and a CH2 group of the alkyl chain is optionally
replaced by O, S, SO, SO2, or NR',
or by a substituted (C6-C12)-aryl radical or hetero-
aryl radical having 1, 2, 3, 4 or 5 identical or
different substituents from the series comprising
hydroxyl, trifluoromethyl, (C1-C8)-hydroxyalkyl,
-O-[CH2-]xCfH(2f+1-g)Fg, -OCF2Cl, -OCF2-CHFCl, (C1-C8)-
alkylmercapto, (C1-C6)-alkylsulfinyl, (C1-C6)-alkyl-
sulfonyl, (C1-C6)-alkycarbonyl, (C1-C6)-alkoxy-
carbonyl, carbamoyl, N-(C1-C4)-alkylcarbamoyl,
N,N-di-(C1-C4)-alkylcarbamoyl, (C1-C6)-alkylcarbonyl-
oxy, (C3-C8)-cycloalkyl, phenyl, benzyl, phenoxy,
benzyloxy, NR'-R", phenylmercapto, phenylsulfonyl,

- 45 -

phenylsulfinyl, sulfamoyl, N-(C1-C4)-alkylsulfamoyl,
N,N-di-(C1-C4)-alkylsulfamoyl, (C1-C8)-alkoxy-
carbonyloxy, (C1-C8)-alkoxy-(C1-C8)-alkoxycarbonyloxy,
(C6-C12)-aryloxycarbonyloxy, (C7-C11)-aralkyloxy-
carbonyloxy, (C7-C11)-aralkylcarbonyloxy, cinnamoyl,
cinnamoyloxy, (C6-C12)-arylcarbonyloxy, (C3-C8)-
alkenylcarbonyloxy, (C3-C8)-alkynylcarbonyloxy,
(C3-C8)-cycloalkylcarbonyloxy, (C1-C12)-alkoxy-
(C1-C12)-alkoxy, (C1-C12)-alkoxy-amino, (C1-C12)-
alkoxy-N (C1-C8)-alkylamino, (C1-C12)-alkoxy-N,N
(C1-C6)-dialkylamino, carbamoyloxy, N-(C1-C8)-alkyl-
carbamoyloxy, N,N-di-(C1-C8)-alkylcarbamoyl,
N-(C3-C8)-cycloalkylcarbamoyl, N-(C8-C12)-arylamino,
N-(C7-C11)-aralkylamino, N-alkyl-aralkylamino,
N-alkyl-arylamino, (C3-C8)-cycloalkanoylamino,
(C1-C8)-alkanoylamino, (C6-C12)-aroylamino, (C7-C11)-
aralkanoylamino, (C1-C8)-alkanoyl-(C1-C8)-alkylamino,
(C3-C8)-cycloalkanoyl-(C1-C8)-alkylamino, (C8-C12)-
aroyl-(C1-C8)-alkylamino, (C7-C11)-aralkanoyl-(C1-C8)-
alkylamino, (C1-C8)-alkylmercapto, (C1-C8)-alkyl-
sulfinyl, (C1-C8)-alkylsulfonyl, (C1-C8)-alkyl-
carbonyl, (C3-C8)-cycloalkylcarbonyl, nitro, tri-
fluoromethyl, phenylmercapto, phenylsulfonyl,
phenylsulfinyl, sulfamoyl, N-(C1-C8)-alkylsulfamoyl,
N,N-di-(C1-C8)-alkylsulfamoyl, (C1-C8)-alkyl-sulfon-
amido and arylsulfonamido, where the aryl and alkyl
radicals in the above substituents can also have a
hererocyclic nature and/or, like alkyl, can be
substituted by 1, 2, 3, 4 or 5 identical or dif-
ferent substituents from the series comprising
halogen, cyano, nitro, trifluoromethyl, (C1-C6)-
alkyl, hydroxyl, (C1-C8)-hydroxyalkyl or (C1-C6)-
alkoxy,
or by a substituted (C6-C12)-aryloxy radical, (C7-C11)-
aralkyloxy radical or heteroaryloxy radical, each of
which has 1, 2, 3, 4 or 5 identical or different
substituents selected from the series comprising





- 46 -
hydroxyl, halogen, cyano, nitro, trifluoromethyl,
(C1-C6)-hydroxyalkyl, (C1-C5)-alkoxy,
[CH2-]xCfH(2f+1-g)Fg, -OCF2-CHFCl, (C1-C6)-alkylmercapto,
(C1-C6)-alkylsulfinyl, (C1-C6)-alkylsulfonyl, (C1-C6)-
alkylcarbonyl, (C1-C6)-alkoxycarbonyl, carbamoyl,
N-(C1-C4)-alkylcarbamoyl, N,N-di-(C1-C4)-alkyl-
carbamoyl, (C1-C6)-alkylcarbonyloxy, (C3-C8)-cyclo-
alkyl, carboxyl, phenyl, benzyl, phenoxy, benzyloxy,
NR'-R", phenylmercapto, phenylsulfonyl, phenyl-
sulfinyl, sulfamoyl, N-(C1-C4)-alkylsulfamoyl,
N,N-di-(C1-C4)-alkylsulfamoyl, aminoalkyl, N-(C1-C8)-
alkylamino-(C1-C12)-alkyl or N-di-(C1-C8)-alkylamino-
(C1-C12)-alkyl and which is substituted by, in
particular, up to 3 of the abovementioned identical
or different substituents, and one CH2 group of the
alkyl chain is optionally replaced by O, S, SO, SO2
or NR',
or by a radical of the formula II
-O-R5 (II)
in which
R5 is an amino acid bonded via its acyl radical, or
a derivative of this amino acid, or an alcohol
protective group,
B a substituted (C5-C12)aryl radical, (C7-C11)aralkyl
radical or heteroaryl radical, each of which is
monosubstituted or polysubstituted, preferably mono-
or disubstituted,
by hydroxyl, amino (C1-C8)-alkoxycarbonyl, (C1-C8)-
alkylcarbonyloxy, (C1-C8)-alkylamino, di-(C1-C8)-
alkylamino, (C1-C6)-hydroxyalkyl, -O-[CH2-]xCfH(2f+1-g)Fg,
-OCF2Cl, -OCF2-CHFCl, (C1-C8)-alkoxycarbonyl,
carbamoyl, N-(C1-C4)-alkylcarbamoyl, N,N-di-(C1-C8)-






- 47 -
alkylcarbamoyl, (C1-C8)-alkylcarbonyloxy, (C3-C8)-
cycloalkyl, phenyl, benzyl, phenoxy, benzyloxy,
aminoalkyl, N-(C4-C8)-alkylamino (C1-C12)-alkyl or
N,N-di-(C1-C8)-alkylamino-(C1-C12)-alkyl, (C1-C8)-
alkoxycarbonyloxy, (C1-C8)-alkoxy-(C1-C8)-
alkoxycarbonyloxy, (C6-C12)-aryloxycarbonyloxy,
(C7-C11)-aralkyloxycarbonyloxy, (C7-C11)-aralkyl-
carbonyloxy, cinnamoyl, cinnamoyloxy, (C6-C12)-
arylcarbonyloxy, (C3-C8)-alkenylcarbonyloxy, (C3-C6)-
alkynylcarbonyloxy, (C3-C8)-cycloalkylcarbonyloxy,
(C1-C12)-alkoxy-(C1-C12)-alkoxy, (C1-C12)-alkoxy-amino,
(C1-C12)-alkoxy-N (C1-C6)-alkylamino, (C1-C12)-
alkoxy-N,N (C1-C8)-dialkylamino, carbamoyloxy,
N-(C1-C8)-alkylcarbamoyloxy, N,N-di-(C1-C8)-alkyl-
carbamoyl, N-(C3-C8)-cycloalkylcarbamoyl, N-(C6-C12)-
arylamino, N-(C7-C11)-aralkylamino, N-alkyl-aralkyl-
amino, N-alkyl-arylamino, (C3-C8)-cycloalkanoylamino,
(C1-C8)-alkanoylamino, (C8-C12)-aroylamino, (C7-C11)-
aralkanoylamino, (C1-C8)-alkanoyl-(C1-C8)-alkylamino,
(C3-C8)-cycloalkanoyl-(C1-C8)-alkylamino, (C8-C12)-
aroyl-(C1-C8)-alkylamino, (C7-C11)-aralkanoyl-(C1-C8)-
alkylamino, (C1-C8)-alkylmercapto, (C1-C8)-alkyl-
sulfinyl, (C3-C6)-alkylsulfonyl, (C1-C8)-alkyl-
carbonyl, (C3-C8)-cycloalkylcarbonyl, nitro, tri-
fluoromethyl, phenylmercapto, phenylsulfonyl,
phenylsulfinyl, sulfamoyl, N-(C1-C8)-alkylsulfamoyl,
N,N-di-(C1-C8)-alkylsulfamoyl, (C1-C8)-alkyl-sulfon-
amido or arylsulfonamido,
C a substituted (C1-C12)alkoxy radical, (C3-C8)-
cycloalkoxy, (C6-C12)-aryloxy radical or a (C7-C11)-
aralkyloxy radical, each of which is monosubstituted
or polysubstituted, preferably mono- or disub-
stituted,
by halogen, trifluoromethyl, (C1-C6)-alkoxy,
hydroxyl, (C1-C8)-hydroxyalkyl, NR'R" or cyano





- 48
where in each case

R' and R" are identical or different and are hydro-
gen, (C6-C12)-aryl, (C1-C8)-alkyl, (C1-C8)-alkyl-
carbonyl, (C7-C11)-aralkylcarbonyl or (C6-C12)-aryl-
carbonyl, or together with the nitrogen, form a
saturated heterocyclic ring, preferably a 5- or
6-membered ring,
and the abovementioned radicals R1, R2, R3 and R4 can
occur in combination
with a (C1-C12)-alkyl radical which is monosub-
stituted or polysubstituted, preferably mono- or
disubstituted, by hydrogen, halogen, hydroxyl,
cyano, amino, carboxyl, (C1-C4)-alkoxy, (C1-C4)-
alkoxycarbonyl, (C1-C4)-alkylcarbonyloxy, (C1-C4)-
alkyl- or (C1-C4)-dialkylamino or with a phenyl ring
which is mono-, di- or trisubstituted by the radi-
cals halogen, nitro, (C1-C4)-alkyl or (C1-C4)-alkoxy,
or in combination
with an aryl or heteroaryl radical, each of which
can, in turn, optionally be mono-, di- or trisub-
stituted by halogen, nitro, cyano, (C1-C4)-alkyl,
(C1-C4)-alkoxy, including all derivatives which have
a suitable protective group in their amino or
hydroxyl groups,
and the physiologically active salts, and
n is 0 or 1,
f is 1 to 8, preferably 1 to 5,
g is 0, 1 to (2f+1), and
x is 0, 1, 2 or 3, preferably 0 or 1.



- 49 -
2. A compound as claimed in claim 1 in which R1 and/or
R3 are hydrogen or methyl and R2 and/or R4 are as
defined in claim 1.

3. A compound as claimed in claim 1 or 2, in which
and/or R3 are/is hydrogen and R2 and/or R4 wherein

A a branched or unbranched (C1-C12)-alkyl radical
which is monosubstituted or polysubstituted
by (C1-C8)-alkoxycarbonyloxy, (C1-C8)-alkoxy-(C1-C8)-
alkoxycarbonyloxy, (C6-C12)-aryloxycarbonyloxy,
(C7-C11)-aralkyloxycarbonyloxy, (C7-C11)-aralkyl-
carbonyloxy, (C7-C11)-arylcarbonyloxy, (C3-C5)-
cycloalkylcarbonyloxy, (C1-C12)-alkoxy-(C1-C12)-alkoxy,
carbamoyloxy, N-(C1-C8)-alkylcarbamoyloxy,
N,N-di-(C1-C8)-alkylcarbamoyl, N-(C3-C8)-cycloalkyl-
carbamoyl, N-(C7-C11)-aralkylcarbamoyloxy or
N-(C8-C12)-arylcarbamoyloxy, where the aryl and
aralkyl radicals in the above substituents can also
have a heterocyclic nature and/or, like alkyl, are
substituted by 1 or 2 identical or different
substituents selected from the series comprising
halogen, trifluoromethyl, hydroxyl, (C1-C3)-alkyl,
(C1-C3)-hydroxyalkyl, (C1-C9)-alkoxy,
-O-[CH2-]xCfH(2f+1-g)Fg, -OCF2Cl, -O-CF2-CHFCl, -(C1-C3)-
alkoxycarbonyl, carbamoyl, (C1-C6)-alkylcarbonyloxy,
(C3-C8)-cyoloalkyl, phenyl, benzyl, phenoxy or
benzyloxy,

or by a substituted (C5-C12)-aryl radical or hetero-
aryl radical which has one or two identical or
different substituents selected from the series
comprising hydroxyl, trifluoromethyl, (C1-C3)-
hydroxyalkyl, (C1-C3)-alkoxycarbonyl, carbamoyl,
NR'R'', N-(C1-C4)-alkylcarbamoyl, N,N-di-(C1-C4)-
alkylcarbamoyl, (C1-C3)-alkylcarbonyloxy, aminoalkyl
or N-(C1-C4)-alkylamino-(C1-C6)-alkyl, where R' and R''
are identical or different and are hydrogen,

- 50 -
(C6-C12)-aryl or (C1-C4)-alkyl,

or by a substituted (C5-C10)-aryloxy radical or
(C7-C11)-aralkyloxy radical which has 1 or 2 identi-
cal or different substituents selected from the
series comprising hydroxyl, halogen, trifluoro-
methyl, (C1-C3)-alkyl, (C1-C3)-hydroxyalkyl, (C1-C3)-
alkoxy, (C1-C3)-alkylmercapto, (C1-C3)-alkylsulfinyl,
(C1-C3)-alkylsulfonyl, (C1-C3)-alkylcarbonyl, (Cl-C3)-
alkoxycarbonyl, carbamoyl, N-(C1-C4)-alkylcarbamoyl,
N,N-di-(C1-C4)-alkylcarbamoyl, (C1-C3)-alkylcarbonyl-
oxy or NR'R'' where R' and R'' are identical or
different and are hydrogen (C6-C10)-aryl or (C1-C4)-
alkyl,

or by a radical of the formula II
-O-R5 (II)

in which

R5 is an amino acid bonded via its acyl radical, or
a derivative of this amino acid,
B is a (C6-C12) aryl or (C7-C11)-aralkyl radidal, pre-
ferably phenyl, benzyl and phenethyl, each of which
is monosubstituted by hydroxyl, (C1-C4)-alkyl-
carbonyloxy, (C1-C4)-alkoxycarbonyl, (C1-C4)-hydroxy-
alkyl, amino, (C1-C5)-alkylamino, di-(C1-C5)-alkyl-
amino, (C1-C5)-alkanoylamino, carbamoyl, N-(C1-C4)-
alkylcarbamoyl, N,N-di-(C1-C4)-alkylcarbamoyl,
carbamoyl, N-(C1-C4)-alkylcarbamoyloxy, N,N-di-
(C1-C4)-alkylcarbamoyloxy, or

C is a (C1-C6)-alkoxy radical, (C3-C6)-cycloalkoxy
radical, (C8-C12)-aryloxy radical and (C7-C11)-
aralkyloxy radical,

n is 0 or 1,

- 51 -
f is 1 to 8, preferably 1 to 5,
g is 0, 1 to (2f + 1),
x is 0, 1, 2 or 3, preferably 0 or 1, and

where the abovementioned radicals R1, R2, R3 and
can occur in combination

with a (C1-C12)-alkyl radical which is monosub-
stituted or polysubstituted, preferably mono- or
disubstituted, by hydrogen, hydroxyl, amino, (C1-C4)-
alkoxy, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkyl- or
(C1-C4)-dialkylamino or a phenyl ring which is mono-,
di- or trisubstituted by the radicals halogen,
nitro, (C1-C4)-alkyl or (C1-C4)-alkoxy, and also in
combination
aryl or heteroaryl radical which, in turn, can
optionally be monosubstituted or disubstituted by
halogen, (C1-C4)-alkyl or (C1-C4)-alkoxy, including
all derivatives which have a protective group in the
respective amino or hydroxyl group, and the
physiologically active salts.
4. A compound as claimed in any of claims 1 to 3, in
which R1 and/or R3 are/is hydrogen and R2 and/or R4
are/is

A an unbranched (C1-C12)-alkyl radioal which is
monosubstituted

by (C1-C8)-alkoxycarbonyloxy, (C1-C8)-alkoxy-(C1-C8)-
alkoxycarbonyloxy, (C8-C12)-aryloxycarbonyloxy,
(C7-C11)-aralkyloxycarbonyloxy, (C7-C11)-aralkyl-
carbonyloxy, (C6-C12)-arylcarbonyloxy, (C3-C8)-cyclo-
alkylcarbonyloxy, (C6-C12)-alkoxy-(C1-C12)-alkoxy,
(C1-C12)-alkoxy-amino, (C1-C12)-alkoxy-N-(C1-C8)-
alkylamino, (C1-C12)-alkoxy-N,N (C1-C6)-dialkylamino,
N,N-di-(C1-C8)-alkylcarbamoyl, N-(C3-C8)-cycloalkyl-


- 52 -
carbamoyl, N-(C7-C11)-aralkylcarbonyloxy, N-(C6-C12)-
arylcarbamoyloxy, (C1-C5)-alkanoylamino,
(C3-C8)-cycloalkanoylamino, (C6-C12)-aroylamino or
(C7-C11)-aralkanoylamino, where alkyl, aryl, aryl-
oxy, aralkyl or aralkyloxy, in turn are sustituted
by hydroxyl or halogen, in particular fluorine,
(C1-C3)-alkyl or (C1-C3)alkoxy,

or by a phenyl radical which is monoubstituted by
a hydroxyl group, or a substituted phenoxy or
benzyloxy radical which is substituted by hydroxyl,
halogen or (C1-C4)-alkoxy,
or by a radical of the formula II
-O-R5 (II)

in which R5 is an amino acid bonded via its acyl
radical, or a derivative of this amino acid which is
substituted on the amino group,

B a (C6-C12)-aryl or (C7-C11)-aralkyl radical, prefer-
ably phenyl, benzyl and phenethyl, which is monosub-
stituted by hydroxyl, and
C methoxy.

5. A compound as claimed in any one of claims 1 to 4,
wherein a compound of the formula (III)

Image
(III)


in which


- 53 -
R6, R7, R8 and R10 are identical or different and are
hydrogen, halogen, cyano, nitro, trifluoromethyl,
(C1-C6)-alkyl, (C1-C6)-alkoxy, -O-[CH2-]xCfH(2f+1-g)Fg,
-OCF2Cl, -O-CF2-CHFCl, (C1-C6)-alkylmercapto, (C1-C8)-
alkylsulfinyl, (C1-C6)-alkylsulfonyl, (C1-C8)-alkyl-
carbonyl, (C1-C6)-alkoxycarbonyl, carbamoyl
N-(C1-C4)-alkylcarbamoyl, N,N-di-(C1-C4)-alkyl-
carbamoyl, (C1-C8)-alkarbonyloxy, (C3-C8)-cyclo,-
alkyl, phenyl, benzyl, phenoxy, benzyloxy, NR'-Rn",
such as amino, anilino, N-methylanilino, phenyl-
mercapto, phenylsulfonyl, phenylsulfinyl, sulfamoyl,
N-(C1-C4)-alkylsulfamoyl or N,N-di-(C1-C4)-alkyl-
sulfamoyl, or two adjacent substituents together are
a chain -[CH2-]n or -CH=CH-CH=CH-, where one CH2
group of the chain is optionally replaced by O, S,
SO, SO2 or NR', Y is 1, 2, 3 or 4, preferably 0 and
1, and the remaining of the substituents R6, R7, R8,
R9 and R10 are as defined above are employed as the
radical (C7-C11)-aralkyloxy.

6. A process for the preparation of a compound as
claimed in any of claims 1 to 5, which comprises
reacting
a compound of the formula IV

Image (IV)

and of the formulae


- 54 -

Image or Image (V)


where R1, R2 or R3, R4 have the meanings given in
claims 1 to 5, and Y is halogen or hydroxyl or
together with the carbonyl group forms an active
ester or a mixed anhydride, and, if appropriate,
converting the reaction products into their physio-
logically acceptable salts..

7. A compound as claimed in one of claims 1 to 5 for
inhibiting proline hydroxylase and lysine hydroxy-
lase.

8. A compound as claimed in any of claims 1 to 5 for
use as fibrodepressants and immunodepressants.

9. A pharmaceutical comprising a compound of the
formula I and an acceptable pharmaceutical
excipient.

10. The use of a compound of the formula I for influenc-
ing the metabolism of collagen end collagen-like
substances as well as the biosynthesis of Clq.

11. The use of a compound of the formula I for treating
disorders of the metabolism of collagen and
collagen like substances and the biosynthesis of
Clq.

12. A process for the preparation of pharmaceuticals for
influencing the metabolism of collagen and collagen-
like substances as well as the biosynthesis of Clq,
wherein the pharmaceutical comprises a compound of
the formula I.


Description

Note: Descriptions are shown in the official language in which they were submitted.


20~2~7~
..
~OECI~ST Ai~TIl5~aGE5ELL5C~AFT ElOI~ 91/F 350 Dr.Fl/bw

De~scription

Pyridine~2,4- and - 2,5-dicar~oxalD.ideE~ asld their der~va
tive~, proc~s ~or their praparation, and their use

5 Compound~ whiah irlhibit thz enzyme~ prolin~ hydroxyla~e
and lysine hydroxylAE~e c~3.u~e~ a highly ~el~ctive inhibi-
tion o~ coll~gen bio~ynt}~esi~3 by a~fecting th~ collagen-
specific hydroxylation reactione. During these reaation~,
protein-bound proliE~e or ly~ine i~ hydroxylat0d by the
10 enzymes proline hydroxyla~e ar~d lysine hydroxyla~e, re~-
pectively. If thi~ r~action is pr~vented by inhibitors,
the result i~ a non-funetio~al, subhydr~xylated collag~n
molecule, of which o;lly a 3m21ll ~mount ~an be released
:~ rc:m the c:ellS~ into the e~tracelluar space~ Moreover, ~he
15 subhydroxylatl3d collagen c:almot be i~oorporated ~nto the
collagen matrix and i~ ~ubject to ~ery rapid proteolytic
degradation. A~ a ~:orlsequ~nce o~ the~e efiects, the total
amount of extrac~llulaxly depo~ited collagen decrea~es .

It is known th~t illhibition oiE proline hydroxylass by
known inhibitors, sus:h a~ dipyridyl, re~ult~ in an
inhihitioh of the Clq bio~ynthe~i~ of ~a~rophage~
~W. Muller et al., FEB~ Lett. 90 (19783, 218; Immun-
biology 155 (1978), 47~. ~he cla~ical pathway o~ c~mpl~-
ment activa~ion i~ there~ore not available. Proline
hydroxyla~e inhibitor~ therefore al~o act a~ in~uno-
depressants, for sxample in Lmmune complex di~order~.

It i8 knowm that the e~zyme proline hydroxyla~e i~
inhibited e~fectively by pyridine-2,4- and -2,5-di-
carboxylic aoid ~. Majamaa et al., ~ur. J. ~iochem. 138
~1984) 239-245). When these compound~ are ueed in aell
cultures, however, they only act aq inhibitor~ when
present in very high con~entration~ (Tschank, G. et al.,
~iochem J. 238 (1987) 625-633).

2 ~ 7 ~
-- 2
~ .
D~-A 3~432,0g4 described pyridine-2,4- ~nd ~2,5-di-
carboxylic ~cid die~ter~ h~vin~ lWB carbon ~tom~ in the
~st~r alkyl ~oiety a8 pharmaceutic~l~ for ~nhibiting
proline hydroxylas~ and ly~ine hydroxyla~e~

5 however, the ~hortcomi~g o $he~e low~r~al~ lated
di~sters i~ that they are too rapildly cle~ved in the
organism to giv~ th~ a~id~, and that they do ~ot reach
the site o~ action in the cel~ in suffici3ntly high
concentration~, which ~ak~s th~m le~ ~ultable for
possihle admini~trat~on ~ pharma~eutical~

DE-A-3,703,959, D~-A-3,703,962 a~d D~-A-3,703,963 pro~ide
the general description of mix~d e~ter/~mide~, higher
alkylated die~ter~ and diamide~ of pyridine-2,4- a~d
-2,5-dicarboxylic acid which are ef~icien~ inhibitor~ of
aollagen bio~ynthesi~ ~n the animal ~odel.

For example, DE-A 3,703,959 de~cribes, inter alia, ths
~: synthe~is of N,N'-bis~2-methoxyethyl)pyridine-2,4-di-
oarboxylic diamide and ~ bi~3-i~opropoxypropyl)-
pyridine 2,4-dicarboxylio diamide.
. .
German Patent ~pplication~ DE-A-3,825,471 and
D~-A-3,828~140 propo~e an impxoved proce~ ~or the
i prepara~ion of ~ bis(2-methoxyethyl)pyridine-2,4-di-
~arboxylic diamide. German Patent ~pplioation
DE~A-3,924,093 propose~ novel ~W'-bi6(alkoxyal~yl~-
pyridine-2,4-dicarbo$ylic diamides.

There wa~ ~ need to ~earch for other oompound~ having an
~mproved pharm~cological activity with regard to the
inhibition o~ lysine hydroxyla8e and proline hydroxyla~e.

Surpri~ingly, it ha8 n~w been found that thi~ object ia
achieved by the following pyridine-2,4- and -2,5-di-
carboxylic diamides.

_ 3 _ 2 ~8~7 ~

The invention therefore relat~s to ~:cDIipou~d~ of the
~ormula I
R1




O ~--N--R2

R'~ (I)
N ~ ~ ~ ~4
o




in which
S Rl, R2, R3 and R4 are identical or differ~nt and are

A a bran~hed or unbr~n~h~d, aliphatic or ~yclo-
aliphatic (C1-Cl2~-alkyl r~di~al, gCl-C~2~-alke~yl radi~al
or a (C1-Cl2)-alkynyl radieal, ea~h o~ which is mono~ub-
~tituted or poly~ub~tituted, prefer~bly mono~ub~ti.tuted
or di~ubstituted,
by ~ ~ Cl-C9 ) -alkoxycarbonyloxy, (C1-Ca)-alkXY~( Cl~Ca )
alkoxycarbonyloxy, (C6--Cl2)-aryloxy~arbonyloxyt (C7-C
aralkyloxy~arbonyloxy, (C~-C~ aralkylcarbonyloxy,
,:cinn~moyl, ~innamoyloxy, ~C6-Cl2)-~rylc~rbonyloxy, ~C8-C8~-
alkenylcarbonylo~y, ~C3-C~)-al~ynylcarbo~yloxy, (C3oC8)-
cycloalkylcarbonyloxy, (C1-C~-alkoxy-(C~-Cl2)-alkoxy,
::~Cl C~)-alkoxy-amino,(C1-C~)-alkoxy-N (C1-C~-alkyl~mino,
12) -alkoxy-~,N (~l-C5)-dialkylamî~o, aarbamoyloxy,
N-~C1-C~)-alkylcarb~moyloxy, ~,N-di-(Cl-C8~ yl~arba~oyl,
~:20 N-(C3-C~)-cy~lo lkylcarbamoyl, ~-(C~-Cl2)-ar~lamino,
N-(C7 C~ arAlk~lam~no, N-alkyl-aralkylami~o, ~-alkyl-
arylamino, (C3-C8 )-cycloalkanoylamino, ~C1 C~)-alkanoyl-
~mino, (C6-cl2)-aroylamino~ (C~-C~ aralkanoylsmino,
(C~-C8);alkanoyl-(Cl-Ca)-alkylamino,( C3 ~Ca)-cyclo~lkanoyl-
(C1-C8)-alkylamino, (C8-Cl2)-aroyl-lCl-C~)-alkyl d no,
(C7-C~ aralkanoyl-(Cl-Ca)-alkylamino, (cl-c8)~a
mercapto, (C1-CB)-alkyl~ulflnyl, (C1-Ca)-alkylsulfonyl,
(C1-C8)-alkylcarbonyl, (C3-C8)-cycloalkylcarbonyl, nitro,

_ 4 _ 2082~7~

trifluoromethyl~ phenylm~rcapto, phenylsulfonyl~ ph~nyl-
sulfinyl, ~ul~amoyl, X3-(Cl-C~-a~ ul~amoyl, ~ di-
(Cl-C~)-alkylaulfamoyl, ~Cl-CB)-Alkyl~ulfonamido and
~ryl~ulfonamido, where the ~ d ~ralkyl radicals in
S the above ~ubotituents c~n ~l~o h~ve a heteroc:yclic
natu:re and/or, lik~ lkyl, are sub~;titut~d ~ 1, 2, 3, 4
or 5 id~ltic:al or d~ ff~ar~nt ~ubl3tituentl3 ~elected :Erom
the ~eriee c:omprising halogsn, cy~no, tlitro, trifluoro-
methyl, ( Cl~C~ allcyl, hydroxyl, ~ ICl-C,3 ) -hydroxyalkyl,
10 (Cl-C6~-alkoxy, ~Q-tCEI2-~sc~ +, "F" -OCF2Cl, -O-CF2-C~FCl,
trif luorom~thyl ~ Cl-Ca ) -alkylDI2roapto ~ B ) -allcyl-

~ulfinyl, tCl-C630alkylsulfoslyl, (Cl-~6)-alkylcarbcnyl,
( Cl-C6 ) -alkoxya~rbonyl, I:arbamoyl, N- ( C~-C" )
carbamoyl, N,N-di-(Cl-C~)-alkylc:arbamoyl, ~Cl~C~)-alkyl-
carbonyloxy, tC3-C8)-cyaloalkyl, phenyl, b~yl, ph¢noxy,
benzylo~y, NR'-R", phenylmercapto, phenyl~ul:Eonyl,
phenyl~ulfinyl, ~ulfamoyI, N-~Cl-C4)-alkylsul~a~oyl or
~,N-di-~C1-C4)-al~yl~ulf~moyl, in p~r~icular by up to 3 of
the abovementioned identiaal or differeAt ~ub~tituent~r
and a CH2 group of the ~lkyl chai~ i~ optionally replaced~
by 0, S, SO, SOz or ~R'9

or by a substituted (C~-C~)-aryl radical or heteroa~yl
radical havin~ 1, 2, 3, 4 or S identical or different
6ub~tituent~ from the series ~omprising hydroxyl, tri-
fluoromethyl, ~C~oC6)-hydroxyal~yl, -O-[C~2~]3C~2~l8)E~
OCF2Cl, -OCF2 C~FCl, (Cl-C6)-alkylmercapto, ~Cl-C~3-~lkyl-
~ulfinyl, (Cl-C6)- lkyl~ul~onyl, ~C~-C6~alkylcarhonyl,
~Cl-C6)-alkoxycaxbonyl, carbamoyl, N-~Cl~C~ yl-
carbamoyl, ~,N-di-(Cl-C~)-alkylcarbamoyl, (C~-C~)-alkyl-
3Q carbonyloxy, (C3-Ct)-cyclo~lkyl, phenyl, benzyl, ph~noxy,
benzyloxy, NR',R", phenylmercapto, phenylsul~onyl,
phenyl~ulfinyl, sulfamoyl, N-(Cl-C~)-alkyl~ulf~moyl,
N,N-di-~C~-Cs)-alkylsulfamo~l, (Cl-C8)-alkoxycArbonyloxy,
(C1-C8)-alkoxy-(Cl-C~)-alkoxycarbonyloxy, (C6-C~)-aryloxy
carbonyloxy, (C7-C1l)-aralkyloxycarbonyloxy, ~C7-C1l)-
aralkyloarbonyloxy, cinnamoyl, cinna~oyloxy, (C6-C~)-
arylcarbonyloxy, ( C3-C~ ) -alkenylcarbonyloxy, ~C3-C8)~

2~7~
- 5 -
alkynylcarbonyloxy, ~C3-C~ ) -cycloalkylcarbonyloxy,
(C~-C~)-alkoxy-~C~-Cl23-~lkoxy, ~Cl-Cl2) alko~y-aminv,
l~l-Cl2)-~lkoxy-N 5Cl C5)-alkylamino, ~Cl-Cl2~-alkoxy-~l,N
(Cl-C~)-dial~yl~mino~ carbamoyloxy, N-(Cl-C~)-al~yl-
c~rbamoyloxy) ~ di-(Cl-CG)-~lkylc~rb~moyl, ~-tC3-C~)-
cycloalkylcarbamoyl, N-(c~-c~)-a~yl~mi~o~ ~-(C7-c~
~ralkylamino, N-alkyl-aralkylamlno/ ~ ~lkyl-aryl ~ no,
(C3~C8)~Cycloalk~noylamlno~(cl-c~)-alkanoylRmino~(c~-c~)~
aroyl~mino, ~C7-C~ aralkanoylamino, (Cl-C~)-alkanoyl-
0 (Cl~c2)-alkylaFino, ~C3-C~) -cyaloalk~noyl-(C~-C~)-alkyl-
amino, lC~-C~)-aroyl-(Cl C8~-alky}amino, (~rCl~)-ar
alkanoyl-~C1 C~)-alkylamino, tCl-Ca)-alkylmercapto, ~Cl-C8~-
alkyloul~inyl, (Cl-Ca) ~lkyl~ulfonyl, (C 8)-
~lkylcarbonyl, ~C3-Ca)-~yc}o lkylcarbonyl, nitro, tri-
fluoromethyl, phenylmercapto, phenylsulfonyl~ phe~yl-
~ 3ll1finyl, ~ulfamoyl, N-(Cl-C6)-alkyl~ulfamoyl, ~ di-
- (Cl-C6)-al~ylsulfamoyl, ~CI_C~ alkyl-sulfon~mido ~nd
arylsulfonamido, where the aryl and alkyl radi~al~ in the
a~ove ~ub~tituents o~n al00 haYe a heterocycli~ nature
and~or, like ~lkyl, oan be ~ub~t~tut~d b~ 1~ 2, 3, 4 or
5 identical or different ~ubstituent~ from the ~eri~
comprising halogen, ~yano, nitro, trifluoromethyl,
( C~_CB )-alkyll hydroxyl, (C~-C~3-hydroxyalkyl or (C~-C6)-
alkoxY r

or by a ~ub~tituted ~C6-Cl2)-aryloxy radical, (C7--Cll)-
aralkyloxy radical or hetero~ryloxy radical, ~ach of
which ha~ 1, 2, 3, 4 or 5 identi¢al or differe~t ~ub-
~tituents selected ~rom the ~eriea ~o~pri~ing hydroxyl,
halogen, cyan~, nitro, trifluoromethyl, tCl-C6)-
hydroxyalkyl, (C1-C8)-alkoxy~ 2-33~5
~OCF2-C~FClr tC~ alkylmercapto, (Cl-C6)-allcyl~ul~inyl~
(Cl-Ca)-alkylsulfonyl, tCl-C0)-alkylcarbonyl, tCl-C6)-
alkoxycarbonyl, carb~moyl, N-(Cl-C~) alkylcarbamoyl,
N,N-di-(Cl-C~)-alkylcarbamoyl, (Cl-C~)-alkylcarbonyloxy,
(C3-C5)-cycloalkyl, carboxyl, phenyl, benzyl, phenoxy,
benzyloxy, NR'-R", phenylmercapto, phenyl~ulfonyl,
phenylsulfinyl, sulfamoyl, N-(Cl-C~)-alkylsulfamoyl,

2~82~
-- 6 --
N,N-di-(CI-C4)-alkylsulfamoyl, aminoalkyl, N-~C1-C8)-
alkylamino-(Cl-Cl2)-alkyl or N-di-(Cl-Ca)-alkylamino-
(Cl-Cl2)-alkyl and which i9 optionally ~ubstituted by up
to 3 o~ the abovem~ntioned identical or dif~erent ~ub-
~titllent~, and one CH2 group of the alkyl chain i~ option-
ally replaeed by O, S, SO, 52 or NR',

or by a radical of the formula II
~5 (II)

in which

R5 is an amino acid bonded via it~ acyl radical, or a
derivative of this amino acid, or an alcohol protec-
tive group,

B a substituted ~C6-C12)aryl radical, (C7-C1l)aralkyl
radical or heteroaryl radical, each of which i~ monosub
stituted or polycub~titutedJ pre~erably mono- or
disubntituted,

by hydroxyl, amino ~C~-C8)-alkoxycarbonyl, (Cl-C8)-alkyl~
carbonyloxy, ~ Cl-c8 ) -alkylamino, di-( Cl-C8 )-alkylamino,
~:: (C1-C6)-hydroxyalkyl, -O-~CH2-]XcfH(2~ )F3~ -OCF2C1,
-OCF2-CHFCl, carbamoyl, N-~Cl-C8)-alkylcarbamoyl,
N,N-di-(Cl-C8)-alkylcarbamoyl, (Cl-C8)-alkylcarbonyloxy,
(C3-Ca)-eycloalkyl, phenyl, benzyl, phenoxy, benzyloxy,
amLnoalkyl, N-(Cl-C8)-alkylamino (Cl-Cl2)-alkyl or N,N-di-
. (cl-ca)-alkylamino-(cl-cl2)-alkyl, (Cl-C8)-alkoxycarbonyl-
oxy, (cl-c8)-alkoxy-(cl-c8)-alkoxycarbonyloxy~ (C6-C12)-
aryloxycarbonyloxy, (C7-C1l) aralkyloxycarbonyloxy,
tC7-Cl1)-aralkylearbonyloxy, cinnamoyl, einnamoyloxy,
(Cg-Cl2)-arylearbonyloxy, (C3-Ca)-alkenylearbonyloxy,
(C3-C8)-alkynylaarbonyloxy,(C3-Ca)-eyeloalkylcarbonyloxy,
(C1-C1z)-alkoxy-(C~-Cl2)-alkoxy, (Cl-Cl2)-alkoxy-amino,
(Cl-Cl2)-alkoxy-N (Cl-C6)-alkylamino, (C~-C~2)-alkoxy-N,N
(Cl-C6)-dialkylamino, earbamoyloxy, N-tC1-Ca)-alkylcarbamo-


2~82~7~
7 --
yloxy, ~, N-di- (C~-C~ alkyl~ 0yl, N- ~C3-C6 ) -cyclo~lkyl-
ca~bamoyl~ N-(C~ ryl~lno, N~t~r~ ral~ylamino,
N-alkyl-arallcylamino, N~ o, ~C~-Ca)-c:yclo-
alkanoylamino, ~Cl-CO) -~lkanoyl~m~no~ ~C~,-C~ royl~no,
(C7-C~ aralk~noyl ~ no, (Cl-Ca)A~Llkanoyl-(Cl-C~,)-~lkyl-
amino, ~ E9-C~ ycloalkanoyl- (Cl-COJ -ell~c3rla~no t (C3-e~
aro~rl-(Cl-C81-alkylamino, (C7~C~ ralk~oyl-(C~ CO)-nlkyl-
A~n~no, ~C1-C8)-a}kylmercapto~ (c~l-c~ k3rl~ulfinyl~
(Cl-~a)-alkyl~lul~onyl~ ~C~-~8)~ carbolly~ 3-C~
10 cyclo~lkylc~rbonyl, nitro, tr~luo~omethyl, ph~nyl-
:~ ~er~:apto, phenyl~ulfonyl, phenylsuli~i~yl, 3ulfæmoyl,
N-(C1-C6)-alkylaulfamoyl, ~9~ di-~C~-C~ alkyl~ulfamoyl,
(Cl-Ct) -alkyl-E~uliEonami do or ~LrylsuliEon2mido,

.
C a substituted (Cl-Cl2) ~lkoxy radical, ( 3-C~ cyclo-
15 alkoxy, (C6-C~2)-aryloxy rAdical or ~ (C~-C~a)-aral~yloxy
radical, each of which i~ ~onosub~itu~ed or polysub~ti-
tuted, pre~erably ~OAO- or di~ubstituted,

~y halogen, tri~luoro~ethyl, (C1-C~ alkoxy, hydroxyl~
( Cl-C~ ) -hydroxyalkyl, ~R ' R ~' or cyano
20 where in each ca~e

R' and R" are identical or different and are hydrog2n,
DC12) -aryl, ( C1-CB) -a ~ C~-C5) -,alkylcarbonyl,
(C~-Cl1~-aralkylcar~onyl or tC6-C~ rylcarbonyl, or
together with the nitrogen, form a saturated heterocyclic
25- ring, pref~rAbly a 5- or 6-m~ r~d ring,

and the abovementioned r~dia~l0 R19 p~2, ~3 ~nd R4 e~ occur
` in combination

with n (C~-C12~-alkyl radical whi~h i~ mc~no~ubsti~uted or
poly~ubetituted, pre~erably mono- or di~ubstituted, }~y
hydrogen, halogen, hydroxyl, cyano, ~mino~ carboxyl,
(C1-Cj)-alkoxy, (C1~C~ lkoxyc~rbonyl f (Cl C4)-alkyl-
carbonyloxy, (Cl C~)-slkyl~ o~ (Cl-C~)-di~lkylamino or with

2~82~7~
- 8 -
a phenyl ring which i~ ~ono-, di- or txi~ub~tituted by
the r~dical~ halogen, n~tro, (C1-C~)-alkyl or ~Cl-C4~-
alkoxy, or in ~mbination

with an aryl or het~roaryl radiaall ~ach of which ~a~
S turn, optionally be mono-, di- or trisub~tituted by
halogen, nitro, cyano, ~Cl-C~ lkyl, ( C~-C4)~ alk9Xy~
including all deri~a~ivas which have a zuitable prot~c-
tive group in ~heir ~mino or hydroxyl group~,
and the phy~iolo~ically active ~alt~ d
n i~ O or 1,
f is 1 to 8, preferably 1 to 5,
g i~ 0, 1 to (2f+1), ~hd
x i~ 0, 1, 2 ox 3, preferably 0 or 1.


Aryl, aryloxy, heter~aryl or heteroa~yloxy ~ompounds are
: 15 -~nderstood as meaning, in particular, phenyl and naphthyl
rin~8~ or unsub~tituted 5- and 6-~embered heteroaromatic
ring~ having l, 2 or 3 ni~rogen and/or oxygen and/or
~ulfur atoms, such a~ pyridyl, pyridazyl, pyrimldyl,
pyrazyl, imidazolyl, triazolyl, thienyl, oxazolyl and
thiazolyl ~eri~atives, nd their benzo-fused derivative~.
The radical ~C7-C~ aralkyloxy ie preferably u~der~tood
as meaning a ~ubstituted phenylalkyloxy radical o~ the
; . formula III


R6 R7


-O -[CH2-lr ~ R~ (III)



Rl R9
in which

2t)82~7~
g

R8, ~7~ R8 ~nd RlQ are identical or di~fer0nt and ar~
hydrogen, halogen, cyano, nitro, txifluorumethYl, (I~ C5~-
alkyl, (Cl-C~ alkoxy, -O-t~2~ CyH~2~ s)F3~ -OCF2Cl~
-O-CF2-CEIFCl, ~ Cl C~ ) -alkylmers~apto, ~ Cl-C~ ~ ~alkylsulf ir~yl,
S (C~-C~ alkylsul~onyl, ~C,-Ca)-alkylcarbonY~ G~-
alkoxyc:arbonyl, carbaDJoyl, N- t Cl C4 ) -alkylc:arlbamoyl,
Il,~-di- ~C~-C~ ~ alkylcarbamoyl, (5~1 C6~ -~lkglcarbonyloxy,
C3-C8 ) -~ycloalkyl, phenyl, benzyl, pherloxy, benzyloxy,
~R'-R", suQh as ~mino, anil~no, ~-methylanilino, phenyl-
10 mer;:apto, phenyl~ul~onylg ph~yls~ Einyl, ~ulf~moyl,~-~C~-C")~alkylsulf~oyl or N,~-di-ICl-C~3-allcylsulfamoyl,
or two adjac~t subst~tuen~r~ together are ~I chain -~CEI2-~n
or -CE~-C~-CB~C~-, where a C~2 group of th~ chain i~
optionally rep}aed ~ O, S, SO, SO2 or NR', Y i3 1, 2~
15 3 or 4 ) pref~rably O and 1, and the remaining o~ the
substituents R6, R7, R8~.R~ and Rl are a8 de~ined above.

o acids which are preferred fxom among~t those
mentioned above are~ in particular, the natural ~-amino
~cid~.

Amino proteative group~ are under~tood ~ aning, in
particular, ~u~h group~ aB are de~cribed in R. ~eiger and
W. ~nig "The Peptides" Volume 3, "Protection of Func
tional Group~ i~ Peptide Synthesi~, B.~. Gro~s,
J. Meienhofer ~dit, AGademic Press, ~ew York (1981l, in
particular pages 7-4~.

Such groups are also deacribed in ~. ~ubbu~h, S~hutz-
gruppen in der Peptidsynthese [ProtectiYe Group~ in
Peptide Synth~Eis], Rontakte 3/791 pag~o 14-23.

Particularly pre~erred amlno protective group~ are the
~oll~wing:

Aoetamidomethyl,
l-Adamantyloxycarbonyl,
l-tl-Adamantyl)-l-methyl-ethoxycarbonyl,

~)82~7~
-- 10 --
Allyloxycarbonyl,
tert-Butyloxycarbonyl,
1~4-Biphenylyl)-l-methylethoxycarbonyl,
Dicyclohexylaarbodilmlde,
~,~-DLmethyl-3,5-dimethoxybenzyloxycarbonyl,
4-Dihydroxyborylbenzyloxycarbonyl,
9-Fluorenylmethyloxyc~rbonyl
l-~ydroxybenzotriazole,
3-Hydroxy 4-oxo-3,4-dihydro-1,2,3-benz~triazine,
I~obornyloxycarbonyl,
l-~ethyl-cyclobutylo~yc~rbonyl r
4-Methoxybenzyloxyc~rbonyl~
~ethyl~ulfonylethyloxycarbonyl,
4~Pyridylmethyloxycarbonyl,
lS 2,2,~-Trichloro-tert-butyloxycarbonyl,
~enzyloxycarbo~yl,
halogen-sub~tituted b~n~yloxycarbo~yl,
4-Nitro-benzyloxycarbonyl J
2-Phosphonoethyloxyc~rbonyl,
: 20 Phenyl~ulfonylethoxyG~rbonyl,
Toluenesulfonylethoxycarbonyl,
~,3,5 Trimethyl-4-methoxy-phenyl~ul~onyl,
Benzotriazol-l-yl-oxy-tri~(dimethylamino)phosphonium
hexafluoropho~phate.

2~ Preferred compound~ ~rom amongst tho~e o~ the ~ormula I
who~e amino groups are protected are those whose pro-
tected amino group i~ part of this amino acid R5.

Suitabls alcohol protective groups axe, in pa~ticular,
~ub~tituted or unsub~tituted ~ethyl ethere, ethyl ethers,
benzyl ether~, silyl ether~, e~ters, carbonates or
~ulfonate~.

rhey embra~e the ollowing compounds:




., .

~ .
:~.

8 ~

A~ ~ubstituted methyl ~thers:
~ethoxymethyl, methylthiomethyl, t-butylthiomethyl,
(phenyld ~ethyl~ilyl)methoxymethyl, benzyloxymethyl,
p-methoxybenzyloxymethyl, ~4-methoxypheno~y)~methyl,
guaiacolmethyl, t-butoxymethyl, 4-pentenylo~ymethyl,
~iloxymethyl, 2-methoxye~hoxymethyl~ 2,2,2-tri~hloro-
ethoxymekhyl~ bia~2-chloroe~hoxy)m~thyl, ~-~trLmethyl-
3ilyl )ethoxymethyl,tetrahydropyranyl~3-bromotetrahydro-
pyranyl, tetrahydrothiopy~anyl~ 1-methoxy~yclohexyl,
4-methoxytetr~hydropyrar,yl, 4-m~thoxytetrahydrothio
pyranyl, 4-methoxytetrahydrothiopyrAnyl-S,S dioxo,
1-~2-chloro-4-me~hyl)-phenyl]-4-methoxypiperidin-4-yl,
1,4-dioxan-20yl, tetrahydrofuranyl J tetrahyfirothio-
furanyl.

As sub titut~d ethyl ethers:
1-Ethoxyethyl, 1-(2-chloroethoxy)ethyl, l-methyl-
l-methoxyethyl, 1-methyl l-benzyloxy~thyl, l-methyl-
1 benzyloxy-2-fluoroethyl, 2,2,~-trichloroethyl, 2-tri-
methylsilylethyl, 2-[phenyl~elenyl)ethyl, t butyl, allyl,-
p-chlorophenyl, p-methoxyphenyl, 2,4-dinitrophenyl,
benzyl.

As ~ubstituted benzyl ethern:
p-Methoxybenzyl, 3,4-dimethoxybenzyl, o nitrobenzyl,
p-nitrobenzyl, p-halogenobenzyl, 2,6-dichloxobenzyl,
p cyanobenzyl, p-phenylbenzyl, 2- and 4-pioolyl,
3-methyl-2-picolyl-N-oxido, diphenylmethyl, p,p'-di-
~itrobenzhydryl, triphenylmethyl, ~-naphthyldiphenyl-
methyl, p-methoxyphenyldiphenylmethy~, di(p-methoxy
phenyl~-phenylmethyl, tri(p-methoxyphenyl)~thyl,
4~(4'-bromophena~yloxy)phenyldiphenylmethyl,
4,4',4"--tris(4,5-dichlorophthalimidophenyl)methyl,
4,4'4"-tris(levulinooxyphenyl)methyl, 4,~4 n -tri8-
(benzoyloxyphenyl)methyl, 3-(imldazole-1,4~-methyl)bis-
(4'4"-dimethoxyphenyl)-methyl, l t 1-bi~(4-me~hoxyphenyl)-
1'-pyrenylmethyl, 9-anthryl, 9-(9-phenyl)x~nthenyl,
9-(9-phenyl-10-oxo)anthryl.

~2~
- 12 -

AB ~ilyl ether~-
Tr ~ethylsilyl; triethyl~ilyl, trii~opropylsilyl,
dim~thyli~opr~pyl~ilyl~ diethyli~opropyl~ilyl, dLm~thyl-
thexyl~ilyl, t butyldLmethyl~ilyl, t-butyldiphenyl~ilyl,
tribenzyl~ilyl, ~ri-p-xylyl~ilyl, triph~nyl~ilyl,
diphenylmethylsilyl, t-butylmethoxyph~enyl~ilyl.

As e~r~:
Formate~, benzoyl fo~mate~ acat~t~, ch~oroa~etate,
dichloroaaet~te, trichlo~oacetate, trif luoroacet~te,
10 Dnethoxya~:etate, triphenylmæthoxyac~etate~ phenoxyacetate,
: p-chloroph2noxyacetate, p-P-phenyla~et~te, 3-phenyl-
propiorlate, 4-oxoperltanoate t l~vul inate ),
4,J.-(ethylenedithio)pentanoate, pivaloate, adamantoate,
cxotonate, 4-1nethoxycrotonate, b~rlzoate,
15 p-phenylbenzoate, 2,4,6-tr~me~thylb~nzoate (m~itoate)~

A~ ~arbonates:
~ethyl, 9-fluorenylmethyl, ~thyl, 2,2,2-tri¢hloroethyl,
2-~trL~ethyl~ilyl)ethyl,2-~ph~nyleulfonyl)ethyl,2-~tri-
phenylpho~pho~io)~thyl, isobutyl, vinyl, allyl, p-nitro-
phenyl, benzyl, p-methoxybenzyl, 3,4-dim~thoxyb~nzyl,
o-nitrobenzyl, p-nitrobenzyl, S-ben~yl thiocarbonates,
4-ethoxy-1-naphthyl, methyl dithiocarbonate~.

Other e~ters:
2,6-Dichloro-4-methylphenoxyacetate, 2,6-Dichloro-
4- ( 1,1, 3, 3 tetramethylbutyl )phenoxyacetate, 2,4-bi~-
(1,1-dLmethylpropyl)phenoxyaoetate, chlorodiph~nyl-
acetate, isobutyrate, monosuGcinate, (~)-2-~ethyl-
2-butenoate (tigloate), O-(methoxycarbo~yl)benzoate,
p P-benzoate, ~-naphthoate, nitrate, alkyl
N~N,N',N'-tetramethylpho~phorodiamid~te, N-phenyl-
carbamate, borate~, dimethylphosphinothioyl, 2,4-dinitro-
phenylsulfenate.


:.

- 2~:~2~7~
~ 13 -
As ~ulfonat0s:
Sulfatss, methanesulfonate (mesylate), benzyl~ulfonate,
tosyl~tee.

The following protective groups are parti~ularly
preferred:
(C1-C~-Alkanoyl, (Cs-C~)-alkylcarbamoyl, d~-(C~-Ca)-alkyl~
~arb~moyl, N-( C3-C~ ~-ayclo~lkylcarbamoyl, (Cl-C5)-alkoxy-
carbonyl, ( C6-Clz ) -a~yloxycarbonyl, (C~ aralkyl
oxycarbcnyl, in part~cular benzyloxycarbonyl, (C8-C~
arylcarbonyl, (C~-C~ aralkylcarbonyl, (C1-CB)-alkyl,
(Cl~C~)~alkoxy-(C1-C~)-alkyl, ~arb~oyl-~C1-C~)-alkyl e~ter,
(Cl-C1O)-acyloxy-(C~-C6)-~lkyl, pr~ferably (Cl-C10)
alkanoyloxy-(Cl-C6 ~; alkyl, benzyloxy-( Cl-C6 ) a~kyl,
benzyloxycarbonyloxy-~Cl-C~ alkyl, ~Cl-C~)~
alkoxycarbonyloxy-(Cl CB)-Alkyl, ~mino acid e~ter~ or
tetrahydropyranyl.

Preferred compound~ of the formula I are tho~e in whi~h
Rl and/or R3 Pre hydrogen or m~thyl and R2 and~or R4 have
the abovementioned ~eanings.

Other preferred ~ompound~ of th~ formula I are those in
which Rl and~or R3 are hydrogen and R2 nd/or Rb are

A a branched or unbranched ~Cl-C12)-alkyl radi~al which
is monosubetituted or poly~ub~tituted
by ( cl-c8 ) -alkoxycar~onyloxy~ (C~-C8)-alkoxy (Cl-Ca)-
alkoxycarbonyloxy, ~C8-Cl2)-aryloxycarbonyloxyl (C~-C11)-
aralkyloxycarbonyloxy, (C7 C ~ aralkylcarbonyloxy,
(C7-Cll)-arylcarbonyloxy, (C3-C8)-cycloalkylc:arbonyloxy,
(Cl-C~2~-alkoxy-~e1-Cl2)-alkoxy, carbamoyloxy, ~-(Cl-C~)-
alkylcarbamoyloxy, ~ di-( C1_CA1-alkyloarb~moyl~
~-(C3-C~ cycloalkylcarbamoyl, ~-~C~-Cl~)~
ar~lkylcarbamoyloxy or N-(C6-Cl2)-arylcarbamoyloxy, where
the aryl and aralkyl radical~ in the above ~ub~tituent~
can al80 h~ve a heterocyclic nature and/or, like ~lkyl,
are sub~tituted by l or 2 identical or different

- 14 - 2~82~7~
~uh~tituent~ selected from the ~erie~ comprising halogen,
trifluoromethyl, hydroxyl, (C1-Ca)~al~Y~ 3 ) -
hydroxyalkyl, (C~-C~)-alkoxy, ~ ~2- ] ~C~2~+~ ~)F6 ~ -OCF2Cl ~
-0-CF2-C~FCl, -(C1-C~-alkoxycarbonyl, sarbdmoyl, ~Cl- C3 ) -
alkylcarbonyloxy, (C3Ca~-~ycloalkyl~ phenyl, benZYlr
phenoxy or ~enzylo~y,

or by a sub&tituted (C8-C~2)-aryl radical or het~roaryl
radi~al which h~8 on~ or two iden~ical or diferent
substituent~ sel~ct~d ~rom the seri~ c4mpri~ing
hydroxyl, trifluoromethyl, [Cl-C3)-hydroxyalkyl, (Cl-C3)-
alkoxycarbonyl, ~arbamoyl, NR'R", ~-~Cl-C~ yl
carbamoyl, ~ di-( C~-c4 )-alkylcarbamoyl, (Cl-C3)-alkyl-
carbonyloxy, A~; noalkyl or N-(C1-C~)-alkylamln-tCl-c~)-
alkyl, whare R' and R~ are identical or differen~ ~nd Are
hydrogen, ~C~-Clz) aryl or (Cl-C4)-alkyl,

or by a substituted (C6-C10)-aryloxy radical or ~C~-C~
aralkyloxy radical which has 1 or 2 identical or dif-
fer~nt substituents s~lected ~r~ the nerie~ comprising
hydroxyl, halogen, trifluoromethyl, (Cl-C3)-alkyl, (~ a)~
hydroxyalkyl, ( Cl-c3 ) -alkoxy, (Cl-C3)-alkylmercapto,
(Cl-C3)-alkyl~ul~inyl, (Cl-C3)-alkylsul~onyl, (Cl-C3)-
alkylcarbonyl t ( C1-C3) alkoxycarbonyl, carbamoyl,
~-(C1~C4)-alkylcarbamoyl, N,N-di-~C1-C~)-alkylcarbamoyl,
(Cl-C3)-alkylcarbonyloxy or ~R'R~ where R' and R" are
identical or dif~er~nt and are hydrogen, (C~-C1O)-~ryl or
~Cl-C4) alkyl,

or by a radic21 of the formula II
R5 (II)

in which

R5 i8 an amino acid bonded via it8 ~cyl radical, or a
derlvative of thi~ am1no acid,

~ ~ 2 ~ 7&
B i~ a ~C6-Cl2) aryl or (C7-C~ aralkyl radical, pre-
ferably phenyl, benzyl and phenethyl, each o~ which i~
monosub~tituted by hydroxyl, (C~ C4)-alkylaarbonyloxy,
(cl-c~)-alkoxycarbonyl~ tCl-C~)-hydroxyalkyl, ~mino,
(Cl-C5)-alkylAmino, di- (C~-C5) -alkyl~mino, (Cl~~s)~
alkanoylamino, carbam~yl, N-(Cl-C~)-alkylcarbamoyl,
N,N-di-(Cl C~ lkyl~arbamoyl t ~rbamoyl, N-(Cl~C4)-alkyl-
carbamoyloxy, N,N~ (Cl-C~)-alkylcarbamoyloxy, or

C iB a tCl-C6)-alkoxy radical, ~C3-C~)-cy~loalkoxy
radical, (CB_C1~ ) -aryloxy radical and ( C7-C~ aralkyloxy
radical,
: n i~ O or 1,
is 1 to 8, preferably 1 to 5,
g is 0, 1 to l2~
x i~ 0, l, 2 or 3J pr~f~rably O or 1, and

wher~ the a~ovementioned radical~ Rl, R2, R3 and R4 can
occur in combination

with a (~-Cl2)-alkyl radioal which i5 monosubstituted or
poly~ub~tituted, pr~ferably mono- or disubstituted, by
hydrogen, haloge~, hydroxyl, amino, (Cl-C4~-alkoxy,
(Cl-C4)-alkoxycarbonyl, (Cl-C~)-alkyl- or (C~-C~)-
dialkylamino or a phenyl ring which i~ ~on~-, di- or
trisubstituted by the radl~als halogen, nitro, (Cl-C4)-
alkyl or (Cl-C4)-alkoxy, and also in ~ombination with a~
: 25 aryl or heteroary.l radi¢~l which, ~n turn, can optionally
be mono~ub~t~tuted or di~ub~tituted by halogen, (Cl-C4)~
alkyl or (C~-C4)-alkoxy, including all derivatives which
have a protective group in the respective amino or
hydroxyl group, and the phy~iologically active aalts.

- ~6 - 2~8~
Particularly preferred compound~ of the formula I are
those ~n which R1 nnd/or ~9 are hydrog~n and R2 and/or Rh
are

: A an unbranched (C~-C~)-41kyl r~dical which i~ ~ono-
~ubstitut~d

by ICl-C~)-alkoxyc~rbonylo~y, ~C1-C~-alkoxy-(Cl-C~)-
alkoxycarbonyloxy, (C~-C~)raryloxycarbonYlO~Y, (C~-C~
aralkyloxycarbonyloxy, ~ C7~ r~lkyl~rbonyloxy,
~C6-Cl2)-arylcarbonyloxy, ~ C3-CB )-cycloalkylcarbonyloxy,
~cl-cl2~-alkoxy-(cl-c~)-alkoxy~ (cl-cl2~ kox~-~mino~
(C1~Cl2)-alkoxy-~-(Cl-c6)-alkylamlno~ (Cl-C12~-alkoxy-N,~-
(C1-C6)-dialkylamino, ~ di-lCl-C~-alkylcarbamoyl,
N-( C3_C~ )-cycloalkylcarbamoyl, ~-(C7C~ aralkylcarbonyl-
oxy, N-(C6-Cl23-arylcarbamoyloxy, (~1-C5~-alkanoylamino,
(C3-C6~-cycloalkanoylamino, (C5-Cl2)-~roylamino or (C7-Cll)-
~: aralkanoylamino, where alkyl, aryl, aryloxy, aralkyl or
aralkyloxy, in turn, are ~ub3tituted by h~droxyl or
halogen, in particular fluorine, (Cl-C3)-alkyl or (Cl-C3)-
alkoxy,

or by a phenyl radical which i~ m~nosub~tituted by a
hydroxyl group, or a ~ub~tituted phenoxy or benzyloxy
radiaal which i~ ~ubstituted by hydroxyl, halogen or
~; (Cl-C~)-alkoxy,
or by a radical of the formula II
-0-~3 (II)
.:
;: in which R5 i~ an d no ~cid bond~d via it~ acyl radical, or a derivative o~ this amino acid which i~ ~ub~tituted
on the amino group,

B a (C6-CI2)-aryl or (C7_C~ ara1kY1 radi~al, pre~erably
phenyl, b~nzyl and phenethyl, which i8 mono~ubstituted by
hydroxyl, and

2~82~ ~
- 17 -

C methoxy.

The invention further~or0 rel~te~ to a proce~s for the
preparation of compound~ of the ~ormul~ I which ~omprises
reacting

a comp~u~d of the ~or~ul~ IV
o

~ - C

; ~ (IV)

C - Y
Il
O
with a compound of the for~ulae V

H - N .~ or ~ V)
R 2 R 4
: ~'
~: where Rl, R2 or R3, R4 are as defined in formula I and Y i8
halogen or hydroxyl or together with ths carbonyl group
form~ an ~ctive ester or a ~ixed ~nhydride, and, if
appropriate, ~onverting the reaction products into their
~ physiologically acceptable ~alts.

- The preparation of oompound~ of the formula I and the
preparation of the st~rting material~ raquired therofor,
unle~ they ar~ com~ercially available, will b~ described
hereinafter in greater detail.

~he ~implest way of preparing the compound~ according to
the invention i~ to combine the two co~ponent~, the
pyridine derivative o~ the formula ~IV~ and the amine of

` - 18 - ~$2~
the formula (V~, in equ~s:)lar am:~unts or in up to
~pproximately 5-~old exce~EI of V, ~.nd ~o react them ~t
t~mper4tures of between -3a and 150C, prefarably at
20 to 100C, until th~ reaction i~s QompleteO The end of
the reaction can }:~e determined 3by mean~ of thin~ yer
chromatography ~DC checlc~. In a varian~ o~ thi3 procea3,
the reaction 1~ o~.rriad ou~; ~n a ~3uit~ble solvent ~uch as
sliethyl ~ther or di~ethoxye~h~ne D~C tet:rahydro~ura~
chlorinated hydrocarbon~ ~uch a~ .methyl0ne 3:hloride~
10 ~hloroform, tri- or t~rac:hloroethylen~, benz~ne, toluene
or ~lse po}ar a301vents such a8 diD~ethy~ ~ormamide or
acetone or dimethyl ~ulf oxide .

In thi~ proee~s too, an exceEIY of amine of khe formula
(V), which ean be up ~o approx. 5 fold, can be u0ed. The
15 reaction temperatures ~re between rooDI k~mperature and
the boiling point o~ the E~olv~nt, temperatures in the
range from room temperature o 13û~C being particularly
preferredO

The reaction carl equally be carried out ~ria a m:Lxed
anhydride such as ethyl ~hloroonmate, or via an acti-
vated ~ter ~uch as paranitrophenyl e~ter (Y ~ CIC~2-COO
or NO2-C6~4-O). Suitable ~ethod3 can be found in ~ouben-
Weyl, Methoden der Organi0chen Chem1e ~Methods in Organic
.Chemistry], Volume XV/2, pages 169 to 183 ~mixed anhy-
-25 dride method), or pages 13 et s~q. (active e~ter method),
fourth ed$tion, Georg Thieme Verlag, Stuttgart 1974.

If appropriate, the reaction can al~o be ~arried out in
the presence of base~. 8uitable additional base~ ~re
inorganic a¢id scavenger~ ~uch RB c~rbonates or hydrogen-
car~onates, for example ~odium carbonate, pota3~iumcarbonate, sodium hydrogencarbonate or potassium
hydrogencar~onate, or organic acid ~cavenger~ ~uch a~
tertiary amines, such a~ triethylamine, tributylami~e,
ethyl diieopropylamine or heterocyclic amines ~uch as
N alkylmorpholine, pyridine, quinoline or

2~2~7~
- lg -
dialkyl~niline~ .

The compounds of the formula (IV) are preferably re~cted
with ami~s of the formula (V~ with additio~ of a w~ter-
el~nating agent ~suc:h ~E~ dialkylcarbodli~nidea where the
5 allcyl radical~ have 1 to 8 carbon ~5to~$3 which, in the
casa of the C3-C9-eompound~, can al~o lbe bram:h~d or
cyclic:; dicycloh~$ylc:arbodiimide ~ pref~rably ~mpls~y~d.
A s~litable laethod iE~ da~cribed in Elouben WQY1 Volume
XV/2, pag~ 103 to ~ thoden der Org~ hen Chemit3
10 [Method3 in Organic ChemiE~try~, 4th ~dition, Georg ~hieme
Verlag, Stuttgart, 1974.

I~ appropriate, the product6 can be worked up for ~ample
by extraction or by chromatography, ~Eor example using
silica gel. The i~3olated prodllct ~an be recrystallized
15 and, i~E appropriatet reac:l:ed with a suit~ble acid to give
a physiologioally act:sptable ~alt. 13xamples oiE ~uitable
acids are:

.
Mineral acid~ BUCh a~ hydrochloric ~nd hydrobromic ~cid
a~ well as sulfurit: acid, pho~phoric ~cid, nitric aoid or
perchloric ~cid, or organic acid~ ~uch a~ forn~c acidl
acetic acid, propionic acid, ~uooinic ~oid, glycolic
acid, lactic acid, malic ~cid, tartaric acid, ~:itric
; acid, maleic acid, fumaric acid, phenylacetic acid,
benzoic acid, methanesulfonic acid, toluene~ulfonic acid,
oxalic acid, 4-~minobenzoi~ acid, naphthalene-1,5-di
: ~ulfonic acid or a~corbic ~oid~

If the ~tarting compounds of the fonmula (V) are not
commercially av~ilable, they can be ~ynthe~ized in a
~imple manner (~or example Organikum, organisch
Chemisches Grundpraktikum CPractical Foundation in
Organic Chemistry], 15th ~dition, VEB Deutscher Verlag
der Wissenschaften, 1976; a survey of the various po~si-
bilitie~ can be found in khe methodological regi~ter,
page 822~.

2 ~ 7 6
- 20 -
For exam~le, the ~tarting compound of the fonmula (IV)
can be obtained by reaeting pyridina,-2,4- or -2,5-di-
earboxylie acid to give tha corresponding pyridine-2,4-
or -2,5-dicarboxylic halide, preferably the chloride (by
proce~es ~nown fr~ the litarat,ure, for example
Organikum, Organi~ch Chemi3che~ Grundpraktikum [Practical
Foundation in Organic Chemistry], 15th ~dition, VEB
Deutsch~r Verlag der Wi~sen~chaften, 1976r page 595 et
8eq. ) ~ which i8 then reacted with ~ ~uitable aloohol, ~or
example paranitrobenzyl ~lcohol, to give the aorrespond-
ing active ester. Equal1y, the pyridine-2,4- or -2,5-di-
carboxylic acid ~an also first be con~erted i~to a mixed
anhydride by addition of a ~uitable ~arboxylic acid or
: carboxylate, such as ethyl cbloroformate, and this mixed
anhydride i8 then reacted with the amine6 (V) to gi~e the
product~ accordi~g to the inve~tion. A ~uit~ble methcd i8
described, or example, in ~ouben-Weyl~ ~etho~n der
Organischen Chemie tMethod~ in Organic Chemistry], Volume
XV/2, pages 169 to 183, 4th Edition, 1~74, Georg ~hieme
Verlag Stuttgart.

The ~ompounds of the formula (I) ~ccording ~o the inven-
~; tion have valuable pharmacologic~l propertie~ and are, in
; particular, e~fective a6 inhibitor~ of proline hydroxy-
aBe and lysine hydroxylase, a~ a fibrodepres~ant r
immunodepre~ant and antiathero~clerotic.

;~ The antifibrotic action can be determined with the aid of
~: the carbontetrachloride-induc~d hepatic fibro~is ~odel.
To this end, rat~ are trQated twice weekly with CCl4
(1 ~l/kg) dissolved in olive oil. ~he test sub~t~noe i~
administered daily, if appropxiste even twice daily,
or~lly or intraperitoneally, dissolved in a ~uitable
acceptable solvent- The extent of hepatic fibrosis i~
determined hy~tologically and the amount of oollagen in
the liver i8 analy~ed by hydroxyproline determination as
described by Kivirikko et al. (Anal. Biochem. 19, 249 et
~eq. ~1967)~. The fibrogenetic ~ctivity can be determined

2Q8207~
- 21 -
by radio ~ unological det~r~instion o~ ~oll~gen ~ra~ments
and procollage~ peptides in ~he ~erum. I~ thi~ mode~, the
compounds according to th~ inv~ntion are active at a
concentration of I-100 mg/kg.

5 The fibrogenet~c activity ~an be determined by radio~
unological determi~ation o~ the ~-terminal propeptide
of the type III collagen or th~ N- or Co~ermi~al cro8~-
linking domain of ~he type IV collagen (7~ ~ollagen or
. type IV ~ollagen ~C1~ in the h~rum.

~o this end, the concentration of hydroxyproline,
procollagen III peptide, 7~ collagen ~nd type IV ~ollagen
NC in the liver wer~ measured in
a) untreated rat~ (control),
b) rat~ who had been adminis~red carbon tetrachloride
(CCl; control) and
~) rats who had been administered ~irst CCl~ ~ollowed
by a c~mpound according to the invention
~: ~thi~ te~t method i~ de~erib0d by Rouiller, CO ~ Experi-
mental toxic injury o~ the liver; in The Liver,
C. Rouiller, Vol. 2, page~ 335-476, N~w York, Academi~
Press, 1964).

Another model for evaluating the antibiotic action i8
that of bleo~ycin-induced pul~onary fibrosis ~s described
by Kelley et al. (J. ~ab. Cli~. ~ed. 96, 954, (1980))~
~he ootton ball granuloma ~odel, as de~crib0d by ~eier et
al., ~xperimentia 6, 4S9 (1950), ca~ be u~ed for
evaluating the action of the ¢ompounds according to the
invention on the granulation ti3~ue.

The compounds of the formula I aAn be uned a0 medicam~nt~
in the form of pharmaceutioal preparations which compri~e
the compound3 of the formula I if appropriate together
with acc~ptable pharma~eutical ~xcip;ents. ~he aompounds
oan be u6ed aR drugs, for example in the ~orm o~ pharma-
ceutical preparations, which compri~e these oompound~ in

2~82~7~
-- 22 --
the f orm of ~ mixture with a pharmaceutic:dl, organic or
inorgar~ic excip~ent which i~ 8uitable for enteral, percu-
taneou~ or parenteral admini~tratl on ~uch as, for
example, inter alia, water, gum nrabic:, gelatine,
5 lactose, starch, ~agn~ tearate, t~lc, ~regetab~
oil~, pc:lyalkylene glycc3ls and vaseline.

To thi~; end, they a~n be dmini~atered orally at do~age
rates o~ 0.1-25 mg/kg/day, preferably 1-5 mgrkg/day, or
parenterally at doE~age rates of 0.01-S ~g/kg/d y, pr~fer-
10 ably 0.01-2.5 mg/kg/day, in pa:rticlllar D.5-1.0 mg/lcg/day.
In ~evere c:a8e8 ~ the dosage ra~e~ an ~150 be increa~ed.
In many c:a~es, however, lower do age rate~ ~uf~ice. q~hese
data are based on an ~dl~lt per~3Qn of ~ bcdy w~ight of
approximately 75 kg.

~` 15 ~he invention furthermore compri~e~ the u~e o:E the
compound~ according to the invention in the preparation
of pharmaceutic:als which can be employed for the treat-
me~t and prophylaxi~ o~ the metabo1ic disorder~ :mentioned
~ above.

: 20 A further object of the invention are pharmaceutical3
:compri~inq one or more compound~ o~ the formula I acGord-
ing to the invention and/or phy~iologically acceptable
~alts thereof.

The pharmaceutical~ are prep~red ~y proaesses which ~re
known per ~e ~na ~amiliar to e person skilled in the art.
A~ pharmaceutical~, the pharmacologically active ~om-
pounds ~ e active substance) according to the invention
are employed either as such or, preferably, in combinn-
tion with suitable pharmaceutical adjuvant~ or excipient~
in the form of tablets, coated tablet~, cap~ule~, ~up-
positories, emulsions, ~u3pensions ox solutions, the
active substance content being up to approximately 95%,
advantageou~ly between 10 and 75%~

2~82~76
- 23 -
Suitable adjuvants or excipient~ for the desir~d pharma-
ceutical ~ormulation are ~ be~ides ~olvents, g~lling
agents, bases ~or 8Uppo8itorie8, tableting adjuvant~ and
other aetive sub~tanc~ ~xcipi~nt~ for example ~l~o
antioxidant~, di~persan~r ~mul~l~ier~, dsfoamers, flAvor
improvers, preaervatives, ~olubilizer~ ~r colorant~.

The invention will be illustrat~d in greater detail
hereinafter with the aid of example~.
~xample 1
lQ Bis-N,N'-~3'-benzoyloxypropyl)pyridl~é-2,4 ~ arboxamide

a~ 25 g (128 mmol3 of dimethyl pyridine~ dicarboxylate
are dissolved in 500 ~1 of ethanol and xe~luxed for 4
hour~ together with 22 ml l282 mmol~ of 3-amino-
~ 1-propanol.
; 15 After the mixkure ha~ bean allowed to ~tand ovexnight at
room temperature, the ~olvent i~ distilled off in vacuo,
and the residue i~ ~rystallized from hot ethyl aaetate;
28.7 g m.p. 102-105C.

b) 0.7 g ~2.5 mmol) of the resulting pyridine-
2,4-dicarboxylic bi~-N,N'-(3-hydroxypropyl)~mide are
combined with 100 ml of di~hloro~eth~e and treated with
0.2 g of 4-~,N-dimethylaLlnopyridine, 0.8 ml (6 mmoll of
triethylamine and dropwi~e ~ith 0.6 ml (5 mmol) of
benzoyl ~hloride. After 1 hourt the mixtur~ i8
concentrated and the ~o~centrate i8 ta~en up in water.
After 1 hour, the mixtur~ i~ extracted twice by 3haki~g
with water ~nd ~he organic ph~e i~ concentrated. The
crude product i~ chro~atographed over silica gel using
ethyl acetate, yield: 0.95 g of colorle~ oil.
Bmpirical formula: C27~27N3O8 (489)
MS: m/e G 490 (M ~

- 24 - 2 ~2 ~ 7
~xample 2

~is-N,N~-~2-(2~m~thylbenzoyloxy)propyl3pyridine-2,4-
diaarbox ~ de

The title compou~d i8 obtained analogou~ly to ~xample 1
fro~ 0.7 g ~2.5 mmol~ of pyridine-~4-di~rboxyllc
bis-~N~-(3-hydr~xypropyl)amide A~ 0.66 ml ~5 ~mol~ of
2-methylbenzoyl chloride, yield: 0.9l0 g of colorl~s~ oil.
~mpirical formula: C2~3lN306 ~517)
~S: m/e = 518 tM ~
,
s~ 10 ~xample 3

2-N-~3-Methoxypropyl)-4-N-[3-(2-methylbenzoyloxy)propyl]
pyridine-2,4-di~arboxamide

.3 g (40 mmol) o~ 4~benzyloxy¢arboDylpyxidine-
~: 2-carboxylic acid Ar~ dis~olved in 160 nl of anhydrous
tetrahydrofuran ~nd, at 0C, treated with 6 ml ~43 mmo~
-~ of triethylamine. After lO minutes, 4.1 ml (43 mmol~ of
ethyl chloroformate are ~dded dropwi~e, and the mixture
i8 ~tirred ~or 30 minutes at 0C-
4.4 ml (43 mmol) of 3-methoxypropylam1ne are then added,
the mix$ure i8 ~tirred for 1 hour at 0C and concentrated
: in vacuo at room temperaturet the product i~ t~ken up in
dichloromethane, the ~ xture iB wa~hed with ~aturated
Na~C03 solution, dried ~d ~reed from ~olvent, ~nd 11.2 g
of 4 benzyloxyaarbonyl~ 3-methoxypropyl)pyridi~-
2~ 2-carboxamide are obtai~ed. 6~0 g (18.3 ~mol) of this
compound are combined ~ith 15 ml of 3-amino-1-propanol
and the mixture i~ stirred for 1 hour at 80C. The exce~.
reagent i~ distilled of~ in v~cuo and the residue i~
crystallized ~rom ethyl acetate, yield: 4.8 g o~
2-N-(3-methoxypropyl)-4-N~(3-hydroxypropyl)pyridine-
2,4-dicarboxamide, m.p. 71-73C.

2~82~76
25 -
2 . O g of this c:o~pound are ~cylat~d ~nalogoll~ly to
~xample 1 u~i~g 2-methylbenzoyl chlorl~e7 A:Eter ~ilic~
gel chromatography using ~thyl ac:~tate, 2 . 4 g o~ the
title compound are obtained ;~ a t:olorlsss;, oily prQduct.
S Bmpirical f o~mulal: C~ 2~N305 ( 413 . 5 )
MS: m/e ~ 414 (M ~ ~)

}Sx~mple 4

2 -N- ~ 3-~ydroxypropyl 3 -4-~- l 3- ~ 2-methy:Lbenzoyloxy ) propyl ~ -
pyridine-2, 4-dicarboxamide

1.6 g ~3.86 mmol~of the title compound of ~xample 3 are
con~ined with 50 ml of di~:hlorome~hane, and 4.5 ml ol~ 1 N
boron tribromide solution in hexane ( 4 . 5 ~mol I are a~de :1
dropwise at -25C. After DC eh~k, a further 1.5 ml of
this solution are added dropwl~e, and, aft~r 0.5 hour,
the mixture i~ he~tad to room templ3rature and extracted
.~ by ~haking with ~3atur~ted N~EIC03 ~olutiorl, the organic
pha~3e i8 dried and s:oncentrated, and the oily re3idue i~
chromatographed on silica gel u~ g ethyl acetate /-
methanol . O . 61 g o~ the title c:ompound crys~tallize ~rom
2 0 ethyl acetate,
m.p- 78-80C
Empirical ~ormula: C2l~25N35 (399-4)
~S: m/e ~ 400 (M + ~)

~xampl~ 5

2-N-~3-~ethoxypropyl)-4-N-[3-(N-cyclohexyl~arbamoyloxy~-
propyl]pyridi~-2,4-dicarbox~mide

2.0 g (6.8 mmol~ of ~-N-(3-methoxypropyl)-4-N-(3-hydroxy-
pxopyl)pyridine-2,4-dic~rboxamide (c~0 Bxample 3) are
dissolved in 250 ml of dichlorometha~e, and 1.05 ml
30 (705 mmol) of cyclohexyl isocyanate are added at 0C with
stirring. The mlxture i8 sub3equently refluxed ~or
1 hour, the reaction i~ checked by mean~ of DC, a ~urther

2~8~7~
- ~6 -
1.1 ml o~ cyclohexyl i~ocyanate ar~ added, the mixture i~
heated ~or a further hour, ~ wed to cool ~nd treated
with water, the organic pha~e i~ dried ~nd con~entr ted,
~nd the oily re~due i~ ¢hromato~r~phsd on silic~ gel
u~ing ethyl acet~te.
Suitable fractions are co~centxated and crystallized
using diethyl ether; yield: 1.1 g o~ the colorle~s
crystalline title compound, m.p. 95-98Co

~xample 6

2-N-~2-Methoxyethyl)-4-N ~3~benzoy}oxyethyl)pyridine-
2,4-dicarbox ~ de

a) 150 g of pyridine-2,4-dicarboxylic acid are ~o~bi~ed
with 1.8 1 o~ methanol and 53.5 g of ~ulfuxic a~id (98~)
and heated ~o ~oiling for 3 hour~. ~fter 1 hour, the
pyridine-2,4-dicarboxylic acid i8 largely di~olved. Only
a ~light cloudine~s remain~ in the mixture~ ~he miYture
i8 poured into ice-water and the fi~ely-crystalline
precipitate i~ allswed to settle~ the ~uper~atant i~
decanted off, the re~idue iB ~iltered o~E with ~ùction,
washed with water and then with a very small amount of
ice-cold MeO~. Yield 70-75 g of 2-methyl-
oxycarbonylpyEidine-4~carboxylic acid, m.p. 246-24~C
(decomp.). The filtrate iB extracted 3 time~ u~ing C~2Cl2,
the organic phases are dried and evaporat~d, the re3idue
i~ taken up in ethyl Acstate, and the mlxture i~ ~iltersd
cver ~ilica gel (appro~. 1 kg). The filtrate i8 evapor-
ted in vacuo. Yield 90 95 g of dLm~thylpyridine-2,4~di-
carboxylat~, ~.p. 61-62C.
.
b) 50 g of 2-methyloxycarbonylpyridine-4-carboxylic acid
and lS0 ~1 of 2-methoxyethyl~mine give 32.5 g of
2-N-(2-methoxyethyl)-4-oarboxamidopyridine-4-carboxylic
acid, m.p. 145.5-146C ~from water).

2~8~76
- 27 -
c) 30 g of the ~bove compound ~re co~bined with 10 ml o~
thionyl chlorid~ in lBO ml of toluens and 1 drop of
d ~ethyl~or~mide, the ~ixture i~ heat~d ~or 3 hours.
When cold, 39 ml of triethylam~ne ~re added, iollowed by
~nhydrou3 meth~nol. Filtr~ion wi~h e~hyl ac~tate through
silica gel and recry~tallization :ErQm methanol/water
gives l9.B g of ~-methyloxycarbonyl~N~ ~ethoxy~thyl)
pyridine-2~carboxamide, m.p. 68-68.5'DC.

d~ 5.0 g of tb~ ~bove compound are co~bined with 10 nl of
tha~olaml~e and thè mlxture i~ heatod to ~oil~ng for
30 minutes. 3.0 g of 2-~-[2-me~hoxyethyl)-4-N-[2-hydroxy-
ethyl)-pyridine-2,4-dio~rboxamide, ~.p. 124-125C, are
obtained in the form of ~olorles~ ~rystal~

e) The title c~mpound i~ obtained, analogou~ly to Example
1 from the above compound ~y reaeting it ~ith benzoyl
chloride in the presence of tri~thylamine and 4-NrN-di-
methylaminopyridine, a~ colorle6~ ~ry~tals, m.p. 77-78C
Empirical ~ormula: C1~zlN305 (371)
~s: m/e - 372 !M ~

2Q Bxample 7

2-N-(2-Methoxyethyl)-4-N-(2-benzoyloxypropyl~pyridine-
2,4-dicarboxamlde

Th~ compound i~ obtained analogou~ly to Bxampl~ 6d) ~nd
6e) a~ a colorle~ oil,
~mpirical ~ormula: C20~23~3~S (385l
~S: m/e - 386 ~M + E~)
r




,::

2~2~7~
- 28 -
~xample 8

2-N-(2~ethoxyethyl)-4-N- r 2-(4-hydroxypheny~)ethyll-
pyridine-2,4-dicarboxamide

~ he kitle ~ompound i8 obtained from 0.24 g of 4-methyl-
oxycarbonyl-2-~-~2-methoxyethyl~pyridin~-2~arboxamide
(cf. ~xample 6c)j by ~eltlng it wi~h 2-(4 hydroxyphenyl)-
ethylamine ~tyr~mine3. FiltratîGn with ethyl ~cetate
through 8iliC~ ~el give~ 70 mg of colorle~ ne~dles; m.p.
181-181.5C ~rom ethyl ~cetate~;
Empirical ~ormula: C1B~21N30~ (343)
MS: m/e = 344 (M +

Example 9

Bi~-N,N'-~2-~4-methylben~oyloxy)-ethyl]pyridine-2 r 4 -di-
carboxamide

~he title compound i~ obtained analogou31y to ~xampLe lb)
~rom bis(N f N'-(2-hydroxyethyl)pyridine-2,4-diaarboxamide
and 4-methylbenzoyl chloride a~ ¢olorle8s ~ry8tal powder,
.p. 1~5-16~C.
Empirical formula: C27~2~N3O6 ~489)
MS: ~/e - 490 ~M + B~)

Example 10

Bi~ 2-ben~oyloxyethyl)pyridine-2~4-dicarboxa~ide
analogou~ly to ~ample lb)
colorle~ needl~s, ~.p. 13g-140C
~mpirical ~ormula: C25~23N3O6 (461)
MS: m/e ~ 462 (M ~ ~t)

The meanings in the tables below are as follow~:
Ph phenyl
Me methyl
30 ~t ethyl

- 29 2~82~
Pr propyl
Bu butyl
~n benzyl
Pen p~ntyl
S ~ex hexyl
T~P tetrahydropyr~noyl
n unbranched ohain
c cycl~
i i~o.

Rl/R2 and R3/R~ ~eans that aither Rl or R2 and R3 or R4,
r~peetivsly, i~ the rad~cal ~entioned. The sub~tituent
which remain~ in each case i~ hydrogen.

The ~ompQunds are in each ca~e 2,4-di~ubstituted pyridine
derivatives.

_ 3~ - 2~2 ~ 7 ~

r~ ----
E~ . Rlt~2 R~
11 CH2 C:H2 0 CO Ph U~, CH~ O CC~ ~h
12 CH2 CH2 0 CO ~h ~ ~a C~Ha O CO NH Et
. . ___ _
13 CH2 Ctl2 0 CO Ph CH2 CH2 0 CO NH-n~u
. . .
14 ~H2 CH2 O CO OEt CH2 ~ 2 0 Cl:) Ph
. . _ _
CH, CH, ~ Ct~ O~ OH, OH, O C:O NH
16 C;H2 CH2 0 CO NH n-8u :;H2 CH2 0 CO Ph
. _ __
. 17 CH, CH, O CO NH ~I~u C--~ CH, O Cc NR n-~u
18 CH2 CH2 O CO NH CH2 CH2 OH CH2 Cl 12 CO NH n Bu
__
. CH2 CH2 0 CO Ntl CH2 CH2 OH CH2 CH~ O C:O NH CH2 CH2 OH
CH2 CH2 0 THP CH2 CH2 0 THP
, ~ ~
21 t:;H2 CH2 0 THP CH2 CH2 0 CO Ph
. ~
22 CH2 CH;, CH2 0 CO Ph CH2 CH2 t:H2 0 ::O Ph
_ . _ .
23 CH2 CH2 CH2 O CO Ph CH2 CH2 t;H2 0 GO NH Et
~ ~--
24 CH2 CH2 CH2 C) CO Ph CH2 CH2 CH2 0 CO NH n-Bu
__ . _ , . , , __
CH2 CH2 CH2 0 CO O Et Ctl2 OH2 CH2 0 C:O Ph
_ ~ __ _ , _ _
26 OH2 CH2 CH2 O O:~ O l~t C~~ CH, CH, l~ CD n~
27 CH2 Cl~2 CH2 0 CO NH n-Bu CH2 CH2 CH2 0 CO Ph
_ . . ~ . , . , _
28 CH2 CH2 CH2 0 ~O NH n-Bu CH2 CH2 CH2 0 CO NH n-Bu .
_ ~

2~2~7~
- 31 -
_~
E ~ . R-~2 ~3/R4

29 CH2 CH2 CHa O t;O NH CH2- C~ C::Ha C:H2 C:tl,2 0 C 0 NH n-Bu
OH
. , . _____
CH2 CH2 CH2 O C :) NH CH2- C H2 CH2 C:H2 CH2 O I C) NH ~C~2
OH C:H2 OH
...... .. _ . _ _ _ _ _ . ~ 11
31CH;~ CH2 CH2 ~P OH2 GHa CH2 0 TllP
~ _ . ~
32CH, C--, CH, O ll ll' CH2 Cl~ CH, O CO I'h
33CH2 CH2 O CH3 CH2 t::H2 C:H2 0 CO c-H~x
34CH2 t: H2 0 CH3 CH2 CH2 C;H2 0 CO ~-Pen
_ , , , . . . _ _ ~
35CH2 CH2 t:) CH3 C:H2 C:H2 CH2 0 C:O O Et l
_ . _ ,_
36CH2 CH2 0 CH3 CH2 CH2 CH~ O CO O n-Bu
.. _ ~ ~
37 CH2 CH2 O OH3 CH2 CH2 CH2 O GO O G Hex
_ .
38 CH2 CH2 0 ~H3 CH2 C:H2 C:H2 0 CO Ph
_
39 CH2 CH2 C) CH3 CH2 CH2 CH2 t:~ CO i-Pr
_ . . . . . _ ~_ _. - ~- I
40CH2 CH2 0 Ct 13 C:H2 C:H2 CH2 0 CO O Ph
~_ . _ _.
41C H2 CH2 0 ~H3 CH2 ~H2 CH2 O CH2 CH2 0 Me ¦
~ . . __ . __
42 CH2 CH2 0 ~ H3 C;H2 CH2 CH2 O CH2 9;;H2 0 Et
~_
43CH2 CH2 0 CH3 GH2 CH2 CH2 Q CH2 CH2 0 Ph
1 - - - - - . , . ... ... ~
44~H2 CH2 O CH~ ~;Hz C;H2 CH2 O Ph
I _ _ ._ . ""_
CH2 CH2 0 CH3 ~ CH2 CH2 CH2 0 THP
~_ . . _ . - , ........ ... .__
46 CH2 CH2 0 CH3 CH2 C:H2 CH2 O CO NH Et
_ _ _ _ . , , l
47 CH2 CH2 0 CH3 CH2 CH2 CH2 0 CO NH Pr
~ __ _ ___ _ _ . ~ , .

48 CH2 CH2 0 CH3 CH2 CH2 CH2 0 C~ N~l ~ Bu

2~82~76
-- 32 --
.



~_ ~ .__I
E x . Rl/R2 R~/R~
_~ ~ ~ I
49 CH2 CH2 O CH3 CH2 GH;, CH2 0 CC) NH c-Hex
, . ,~ . . . ~ I
CH2 CH2 OH CH2 CH;~ CHa O CO c-Hex l
. ._ . _ ~
51 CH2 CH2 0~1 CH2 GH2 CH2 1 ) CO c-P~nt
_ , _ , , .
52 CH2 CH2 OH CH2 t::H2 CHi Q C;O O Et
,,, . ,, , _
53 CH2 CHa OH GH~ CHa CH2 O CO O n-Bu
,., ~
54 CH2 CH2 OH CH2 ~H2 CH2 0 CC) O c-H~x
CH2 CH2 OH O~, CH, CH, O CO (~ Ph
56 CH2 CH2 OH C~l2 CH2 CH~ C) CO ~2-Me Ph)
CH, CH, OH CH2 C:H2 CH2 0 CO Ph
~8 CH2 CH2 OH C:H2 CH2 CH2 0 CH2 CH2 CH
O- lUle
~ ~ .. . , . . .. _ _
59CH2 CH2 OH CH2 CH2 CH2 O CH2 CH2 CH
~:~ ~ O- Et
60CH2 CH2 OH ~2 ~ t~2 CH2 O CH2 CH2 C:H
O Ph
~ _ . _
61CH2 CH2 ~ CH2 CH2 CH2 O Ph l
I
62O--, CH, 011 CH, C--, CH, O T--P
63CH2 CH2 OH CH2 C:H2 C:H2 CO NW Et l
_ _ .. . I
64 CH2 CH2 OH C~12 CH2 CH2 0 CO NH Pr
.. _ _ _ . .. _ _ . ....... ._~._. . --l
65 . CH2 CH2 OH CH2 CH2 CH2 0 ~ 0 NH n-Bu
66 CH2 CH2 OH CH2 CH2 CH2 0 C:O NH c-Hex. . _ -. . _ I
67 CH2 CH2 OH ___ CH2 CH2 CH2 O CO NH Ph l

2~2~7~
-- 33 --
.



_ ~ I
E ,~ R1/R~ R3/R4
I ~__ ~ , ._ ~ I
68 C ~2 C~H2 CH2 ~ CH3 ~H2 ~H2 ~Ha t O C-HBX
._v____ - _ ~ I
69 - C H2 C~H2 ~H2 ~ HJ ~H2 ~H2 ~;H2 CO C- P~n
. . .__ . I
~H2 ~ i i2 C H2 O CH3 CH2 CH~ CH2 C ) CC) O Eth
_ , ~--~
71 CH2 CH2 CH2 0 CH~ . 5;H2 ICH2 CHa O CO t) n-8u
. ~ _~
72 CH2 t~H2 ~H2 ~ HJ ~H2 CH2 CH2 C ) CO O c-Hex
, ~ . ~ _~
73 CH2 ~ H2 ~; H2 O CH3 CH2 CHa Cl'l2 CO Ph
I . ~.
7~ CH;2 CH2 C::H2 0 CH3 CH2 ~H2 CH;~ C) CO i-Pr
_ ~
1 75 CH2 Ct12 CH2 O CH3 CH~ C H2 C H2 O Ce) O Ph
I ~,
I76 CH2CH2CH2O~H3 CH2CH2CH2OCH2~H2M@
.
I77 CH2 CH2 C~2 O CH3 ~2 C H2 ~ H2 CH2 CH2 O Et
_ _ . . ,_ ~ _
I78 CH2 ~ H2 CHa C3 ~H3 ~ H2 ~ H2 t~H2 O CH2 CH2 O Ph
~ . - ....... .. __ . . ~
79 CH2 CH2 ~H2 ~H3 CH2 eH2 CH2 Ph
80 CH2 C~H2 ~H2 ~ H3 CH2 CH2 ~ H2 THP
_ . , . , .. . 11
~ R1 CH2 CH2 CH2 0 CH3 CH2 CH2 CH2 0 CO NH Et
~ , , , . _ . . , . .... ~
l ~2 CH2 C~2 CH2 0 CH3 CH2 CH2 CH2 0 CO NH Pr
- ~ A
83 CH2 ~H2 ~ H2 O C~l3 CH2 CH2 CH2 O CO NH n-Bu
84 CH2 CH2 CH2 0 ~H3 C:H2 CH2 C:H2 0 CO NH c-Hex
, ,
Ctl2 CH2 CH2 OH CH2 C:H2 CH2 0 CO c~tlex

_ _ ~ ~ ~ _ ...... ... ~, _. --
86 CH2 CH2 CH2 OH CH2 CH2 CH2 0 C:O c-Pen
__ _ _ __ , ~ , . ~ _ ~
I 87 t:~H2 ~H2 CH2 OH CH2 ~ :H2 ~H2 CO C-Et
_ _ , " ", " " .. ,
1 88 C;H2 CH2 CH2 OH CH2 C:H2 CH2 0 C:O C n~Bu
_ __ . .__ __ . ~
_CH~ CH2 t::H2 OH _ CH2 CH2 CH2 0 ~O O c-Hex

2~2~7~
-- 34 --

_ I
E~. R /R R3/~4
I . ., ~ I
CH2 CH2 CH2 OH ~ C~ 1`4 ~ CO O Ph
91 t J'12 ~ H2 CH2 OH ~ ~a e H2 C~z ~ CO ~2~Me Ph)
! ~
92 CH2 CH2 CH2 OH C:H2 CH2 C ~2 C~ Ph
. . ~
93CH2 CH2 CH2 OH CH2 CH2 CH2 0 CH2 CH2 CH2
~ Ms
_ _ I
94CH2 CH~ CH2 OH GH2 GH2 t :H2 O CH2 CH2 CH2
O- Et
_
95CH2 CH2 5H2 OH CH2 CH2 CH2 O ~H2 ~H2 CH2
O- Ph
I . .. __ v~_u ~
1 96CH2 ::H2 CH2 OH CH2 CH2 CH2 O Ph
_ ~ ~
97CH2 CH2 CH2 OH CH2 CH2 Ctl2 O THP
. . ....
98CH2 CH2 CH2 OH CH2 CH2 CH2 0 CO NH R
_ _ _ , _,_,_ __, _ _ r . ,_ ::
l 99CH2 C:H2 CH2 OH GH2 CH2 CH2 0 CO NH Pr
_ _ , . ..... .. ~ -- _
1100 CH2 CH2 CH~ OH CH2 CH2 CH2 0 CO NH n-Bu
.. . _ ,, ~ _ .
1 101 CH2 CH2 Ctl2 OH CH2 CH2 CH2 0 CO NH c-Hex
. _ .,
10Z CH2 CH2 CH2 OH CH, C~, CH, O CO N~l Ph
¦ 103 C~2 CH2 CH2 0 CO c-Hex CH2 CH2 0 ~Ae
. . . _ __
104 ~2 ~;H2 CH2 0 CO c-Pen C:H2 CH2 0 M~
_ , . ..... .. _
l 105 CH2 CH2 CH2 O CO O Et CH2 CH2 O Me l
__ _ ~ -- . ~ .. .....
106 CH2 CH2 CH2 0 CO O n-Bu CH2 CH2 M~
_ __. _ _ , _ , _
1 107 CH2 CH2 CH2 0 C :) O c-Hex CH2 CH2 0 Me
. . _ _ - ._ . _
I 108 Cl12 Ctl2 GH, O CO O Ph CH2 CH2 0 Me

2~82~7~
-- 35 --

~--.__~
E x . F~' /R' R'j~'
109 ~H2 ~H2 CH2 O C 2-M~ Ph t~H2 ~H2 O MB
_ ~ .
110 C:H2 CH2 CH2 0 C:O Ph CH2 C;H2 0 Me~
,. _~
111 t::H2 CH2 CH2 0 C:H2 CH2 CHa ~ CH2 ICHa O Me
Me
I ~__




112 C:H2 C:H2 CH2 0 THP CHa CH2 0 M~
,_~
113 C;H2 CH2 C:H2 0 CO NH Et CHa CH2 Q M~
_ -.. ---- ............. _ ___ . ~_ ,
1 1 4 CH2 CH2 C H2 0 CO NH Pr CH2 CH2 ~ M~ -
_ , . _ _
I 1~5 CH2 CH2 CH2 0 C NH n B~ ~H2 CH2 M~
~ ,, _ _ _ _ _ .
I 116 CH2 CH2 t~H2 0 CO NH C-H~X ~;H2 ~H~ O M~
_ ~
¦ 1~7 CH2 CH2 CH2 0 CO NH Ph CH2 CH2 0 Me
r
118 Ctl2 C:tl2 CH2 0 CO c:-H~x GH2 C:Ha C:H2 0 Me
. ~ - ~ _ _ _ ~ ...... _ ~ I
I 119 CH2 CH2 CH2 C ~-Pen ~H2 ~H~7 CH2 Me
~ _ ~
120 CH2CH2CH2OCOOEt C:H2CH2C~2OM~ l
... . ~ .. __ __ , , I

1 121 C:H2 CH2 CH2 0 CO O n-BuCH2 CH2 CH2 0 Me
,_ , . - ._ ~ , ~
122 CH2 CH2 CH2 0 CO O c-HexCH2 CH2 CH2 0 Me
_ , ,_, ..
123CH2 CH2 CH2 C) CO O PA CH2 CH2 CHa O Mi~
r _ -- -- -- -- _ _
124 CH2 Clt2 CH2 0 CO 2-Me Ph CH2 CH2 t H2 0 Me
__ , ,,, _- ~
125 CH2 CH2 CH2 O CO Ph C~2 CH2 C:tl2 0 Me
_ ~ _ _ _ _ I
126 CH2CH2CH20CH2CH2S~H20 CH2CH2~H20Me
Me
_ ~ _ _
127 CH2 CH2 CH2 THP CH2 CH2 CH2 Me
__ . . __
128 CH2 CH2 CH2 0 CO NH Et CH2 CH2 CH2 0 Me
.

- 36 2~8~

~ ~ ~_ I
E~ . R~/~ R3/~
. . . _ . . ~
129 ~ ~2 C~2 C H2 CO NH Pr CH2 CH2 CH2 0 M~
. I
13D CH2 C:H2 OH2 0 GO NH n-Bu g:tl2 CH2 CH2 O M~
, _ . . ... _
131 C;H2 C:H2 t;ll2 0 ~O NH c-H~x C:Ha tCH2 CH2 O Me
.
132 CH2 CH2 C:H2 ~ CO Nl I Ph CH2 CH2 CH2 0 M~
. ~ ~
133 C:H2 CH2 OH2 0 CO e-Hex OHa CH2 CH2 OH
. . ___ ;
134 CH2 CH2 C:i 42 CC) c-~n GH2 CH2 C:H2 OH
. . _ . .
13~ CH2 CH2 CH2 0 CO O Et C:H~ CH2 CH2 C)H
. _ . _ I
136 CH2 CH2 CH2 O eo o n-Bu C;H,2 CH2 CH2 OH
_, .
137 CH2 Ctl2 CH2 O CO O c-l lex C:H2 :::H2 C :H2 OH
~ _
138 CH~ CH2 t;H2 O CQ O Ph OH2 CH2 CH2 OH
139 CH2 CH2 CH2 O CO 2-Me Ph ~ ~2 C:H2 C:H2 OH
. . ~
140 CH2 CH2 CH2 0 CO Ph CH2 CH2 CH2 OH l
~ .~ ~
141 OH2 CH2 CH2 0 Ch2 CH2 CH2 - CH2 Ctl2 1~ OH
Me
~ ~ - ~ - - I
142 Ctt2 CH2 CH2 0 THP GH2 CH2 CH2 OH
~ _ _ _ _ __ _
143 C:H2 CH2 CH2 0 CO Nll Et t::H2 CH2 CH2 OH
_ _ ___ .
144 t::H2 CH2 CH2 0 C:O NH Pr CH2 CH2 CH2 OH l
_ . . , _ _ I
~45 CH2 CH2 CH2 0 CO NH n-Bu CH2 CH2 CH2 C)H
_ _ ~ I
146 ~H2 CH2 CH2 O CO NH c-ttex CH2 CH2 C:H2 OH
._ . ~ __ _ , , _
147 CH2 CH2 CH2 0 CO NH Ph CH2 CH~ CH,2 OH l
_ _ . ~ I
148 CH2 CH2 CH2 O CO c-Hex CH2 CH2 OH l
__ . . . _ . _ . _ _ I
149 CH2 CH2 CH2 0 CO c-Pen CH2 Ctl2 OH

.

- 37 - 2 ~82 ~ 7 ~

Es. R /R ~/~
150 CH2 CH2CH2O CO O R CH2C~2 OH
_ __~
151 CH2 Ctl2 C:H2 0 t:O ~ n-E~u CH2 Cl 1~ OH
__ __
1~2 CH2CH2CH2O CO O C Hex CH~ CH2OH
. ~
. 153 CHaCH2CH2O CO O Ph . CH2 C~2 ~H
_ ~
~4 ~H2 CH2 CH2 O CO 2-Me Ph I::H;~ CH2 OH
155 CH2 C:H2 CH2 O CO Ph CHa Cl 12 OH
., _ , . _ ~.. ,, . ,, _ , ~
156 CH2 CH2 CH2 t:) CH2 CH2 CH2 - C;H2 CH2 OH
Me
_ . . . _ ~_
: 157 ~2 ~H2 CH2 O THP CH2 CH2 OH
, ~ ~
158 CH2 CH2 CH2 0 CO NH E~ C:H2 CH2 OH
. _
159 CH2 CH2 Clt2 0 CO NH Pr CH2 C;H2 ~H
_
160 CH2 CH2 CH2 C) CO NH n-Bu CH2 Ct''12 OH
_ ~
161 GH2 C~12 CH2 0 CO NH c-Hex CH2 CH2 OH
162 CH2 ~H2 CH2 0 CO NH Ph CH, Ol l, (~11


~` ~xample 163

Bi~-~,N'-[2-(4-hydroxyphenyl)-ethyl~pyridine-2 J 4 -di-
carboxamide
Analogously to B~mple 8 from dL~ethyl pyridine-2,4-di-
carboxylate and tyrnminecolorle~s cry~t~l~, m.p. 165-166C
~mpirical formula: C23~23N3O4 ~4D5)
MS: m/e - 40 (M + ~)

2~2~
. - 38 -
-


Example 16~

Bi 8 t~ thoxy--N-methyl~pyridine-2,4-dic~rbox ~ de

5.1 g ~40 mmol) of N-ethylmo~pholene are ~dded ~t 20C
with stirring to 1.67 g (10 mmoll of 2~4-pyridinedi-
carboxylic acid, ~u~pended in 100 ml of diahloromethane,
~.9 ml (20 ~mol~ o~ i~obutyl chloro~ormate are ~ubse-
qu~ntly added dropwi~e ~t -15C, and the ~ixture i~
~tirred for 20 minute~ at lO~C~ 1995 ~lacuna~ (20 mmol)
o~ ~,O-dimethylhydroxyl~mi~e hydrochlorid~ are then
added, the mixture i~ ~tirred for 1 hour ~t -15C and
allowed to come to 20C o~ernight, wat~r i8 add~d, the
mixtur~ i8 extracted with dichloxomethane, a~d, after
puri~ication o-E ~he crude product by column ~hrom~-
tography over silica gel (ethyl acetate/methanol ~ lOJl)~
1.6 g of the ti~le co~pound are obtained a~ a colorl~s
oil,
Empirical formula: C~ 5~304 (253)
MS: m/e - 254 (M + ~+)

Example 165

2-N~ -Methoxyethyl)-4-N-(ethyloxy(N-tert.butyloxy-
carbonylglycyl))pyri~ine-2,4-dicarboxamlde

0.8 g (3 mmol) of ~-N-(2-~ethoxyethyl)o4-N-~2-hydroxy-
ethyl)pyridine-2,4-dic~rbox~mide ~aompound o~.x~mple 6d)
i8 combined with 25 ml of anhydrou3 ~cetonitrile and
~25 mg (3 mmol) of N-butyloxycarbonylglycine, 0.4 ml
(3 mmol) o~ N-ethylmorpholine~ 0O45 g ~3.3 m~ol) of
N-hydroxybenzotriazole and 0.62 g (3 mmol) of ~ di-
cyclohexylcarbodilmide, And the mixture i~ ~tirred for 20
hours ~t 25C. ~he resulting N,N-dicyclohexylurea is
filtered off with suction, washed with acetonitrile ~nd
concentrated, the product i~ taken up in dichloromethane,
the mixture i6 extracted with saturated aqueous Na~CO3
801ution, the extract i~ ~haken with 10~ atrength ~queous

2~82~7~
- 39 -
citric acid, dried ~nd freed from solvent~ and the
residue i8 chromatographed over ~ilica gel.
~mpirical formula: Cl~29N407 (4~4)
~S~ 425 ~

~urther ~xamples are: I ynths~ized ~rom the ~ompound
2-N-(2-mathoxyethyl)-4-~-(2 hydroxyethyl~pyridine-
2,4-carboxamide described in ~x~mple 6d), or from
~nalogou~ ~ompound~, by benzylation)

2-~ (2-Methoxyethyl~-4-~-(2-benzyloxye~hyl)pyridine-
2,4-dicarboxamide

2-N-(2~ydroxye~hyl)-4-N-(2-benzyloxye~hyl~pyridine~
2,4-dicarbox~mlde

2-N-~3-~ethoxypropyl)-4-~-(2-ben~yloxyethyl)pyridine-
2,4-dicarboxamide

2-N-~2-~ydroxypropyl)-4-N-(2-benzyloxyethyl)pyridine-
2,4-dicarboxam~de

Bis-N,N'-[benzyloxyethyl)pyridine-2,4-dioa:rboxami~e

(N,N'-Benzyloxypropyl)pyridine-2~4-dicarboxamid~

2-N-(2-Methoxyethyl)-4-N-[2-~4-fluorobenzyloxy)ethyl3-
pyridi~e-2,4-d~carb~xamide

2-N-~2-~ydroxyethy~)-4-N-l2-(4~fluorobenzyloxy)ethyl]-
pyridine-2,4-dicarboxamide

2-N-(3-~ydroxypropyl)-4 N-[2-(4-fluoro~enzyloxy)ethyl]-
pyridine-2,4-dicarboxamide

2-N-(2-Methoxyethyl)-4 N-~2-(4-methoxybenzyloxy)ethylJ-
: pyridine-2,4-dicarboxamide

2082~ ~6
- 40 -
2-N-~2-~ydroxysthyl)-4-N- r 2-(4-methoxybenzyloxy)ethyl]
pyridine-2,4-dicarboxamlde

2-N-(2-~ydroxypropyl)-4-N-t2-(4-~ethoxybenæyloxy)ethyl]~
pyridine 2,4-dicarbox~mide

2-N-~2-Benzyloxyethyl34-~-(4-hydroxyethyl~pyridine-
2,4-dic2rboxnmlde

2-M-(2-~enzyloxyethyl)-4-N~(4-hydroxypropyl)pyridine-
2,4-dicarboxamlde

2-N-~2-Benzyloxypropyl)-4-N-33-hydroxypropyl)pyridine-
2,4-di~arboxamide

2~ 2-(4-Chlorobenzyloxy)ethyl~-4-~-(2-hydroxyethyl)-
pyridine-2,4-dicarboxamide

2-N-~2~ Chlorobenzyloxy)ethyl]-4-~-(3-hydroxypropyl)-
:~ pyridine-2,4-dicarboxa~ide

2-N-~2-Methoxyethyl)-4-N-t2-benzy~oxypropyl~pyridine-
2,4-dicarboxamide

2-N-(2-~ydroxyethyl) 4-N-~2-benzyloxypropyl)pyridine-
2,4-dicarboxamide

2-N-(3-Methoxypropyl)-4~ 2 benzyloxypropyl)pyridine-
~;~ 20 2,4-di~arboxamide

2~ 2-~ydroxypropyl)-4-~-(2-benzyloxypropyl)pyridine-
2,4-dicarboxamide

2-N-(2-Methoxyethyl)-4-~[2-(4-fluorobenzyloxy)propyl]-
pyridine-2,4-dicarboxamide

2-~-[2-Hydroxyethyl)-4-N-[2 (4-fluorobenzyloxy)propyl]-
pyridine-2,4-diaarboxamide

~08207bj

- 41 -

2-N-(3-~ydroxypropyl~-4-N-[2-(4-fluorobenzyloxy)propyl3-
pyridine-2,4-dicarboxamlde

2-N-(2-~ethoxy~thyl)-4~ 2-~4-msthoxybe~æyloxy)propyl~-
pyridine-2~4-dioarbox~mide

2-N ~2-~ydro~yethyl~-4-~-t2-~4-methoxybenzyloxy)propyl]
pyridine-2,4-dicarboxamide

2-N-~2-~ydroxypropyl)~4-~-t2~(4-methoxybenzyloxy)propyl]-
pyridine-2,4-d~carboxamide

2-N-(2~Benæyloxypropyl)-4-N-t2-hydroxyethyl~pyridine-
2,4-dicarboxamide

2-N-~2-Benzyloxypropyl)-4-~-(3-hydroxypropyl)pyridine-
2,4-dicarboxamide

2-N-[2-t4-Chlorobenzyloxy)propyl]-4-N-~2-hydroxyethylj-
pyridine-2,4-dic~rbox2mide

2-N-1~-(4-hlorobenzyloxy)propyll~4-N-~3-hydroxypropyl)-
pyridine-2,4-dicarboxamide

2-N-(2-~ethoxyethyl)-5-N-~2-benzyloxyethyl)pyridine-
2,5-dicarboxa~ide

2-~-(2-~ydroxyethyl~-5-~-(2-be~zyloxyethyl~pyridine-
2~5-dicarboxamide

2~ 3-Methoxyp~opyl)-5-~-(2-b~nzyloxy~thyl~ pyridin~-
2,5-dicarboxa~ide

2-N-~2-~ydroxypropyl)-5-N-~2-benæyloxyethyl~pyridine-
2,5-dicarboxamide

Bi~-N f ~ benzyloxyethyl)pyridine-2,5-dicarboxamide

2~g~07~
- 42 -
.




(N,N~-Ben~yloxypropyl)pyridi~e-2~5-dioarboxamlde

2~ 2-Methoxyethyl~ N-t2-(4-fluorob~nzyloxy)ethyl3-
pyridine-2,5-dicarboxamide

2-N-~2-~ydroxy~thyl)-5~N-[2 (4-fluorobenzyloxy~et~yl]
pyridi~e-2,5-dicarboxamide

2-N-(3-Hydroxypropyl)-5~ 2-(4-~luQrobenzyloxy )ethylJ-
pyr~dine-2,5-dic~rbox~mide
,
:~ 2-N-(2-Methoxyethyl~-S-N-t2-(4-methoxybenzyloxy)ethyl~-
pyridine-~,5-dicarbox~mide

2-N-(2-~ydroxyethyl)-5-N-[2-~4-~thoxyben~yloxy3ethylJ-
pyridine-2,5-dicarboxamide




2-N (2-~ydroxypropyl) o5-N- 1 2- (~-~ethoxybenzyloxy3ethyl]-
~ pyridine-2,5-di¢arboxamide

: 2-N-(~-Benzyloxye~hyl)-5 N-t2-~2-hydroxye~hyl)pyridine-
2,5-dicarbox~ide

~-N-(2-Benzyloxyethyl)-~-N-[2-(3-hydroxypropyl)pyridine-
2,5-dicarboxa~ide

2 -N ( 2 -Ben zyloxypropyl ) ~5~~~ t 2 - ( 3-h~droxypropyl ) pyridine-
2, 5 dicarboxami~e

2-N-[2-~4-Chloroben~yloxy)ethyl~-5-N-( 2 -hydroxyethyl ~ -
pyridine-2,5-dicarboxamide

2-N-[2-(4-Chlorobenzyloxy~ethyl~-5-N-l3-hydroxypropyl)
pyridine-2,5-dicarboxamide

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(22) Filed 1992-11-04
(41) Open to Public Inspection 1993-05-06
Dead Application 1995-05-06

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1992-11-04
Registration of a document - section 124 $0.00 1993-05-18
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
WEIDMANN, KLAUS
BICKEL, MARTIN
GUENZLER-PUKALL, VOLKMAR
SCHUBERT, GERRIT
HOECHST AKTIENGESELLSCHAFT
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1993-05-06 1 15
Claims 1993-05-06 12 578
Abstract 1993-05-06 1 12
Cover Page 1993-05-06 1 31
Representative Drawing 1998-09-22 1 2
Description 1993-05-06 42 2,085